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1. Introduction 
Multicellular organisms strictly depend on their immune system to cope with potential pathogens 
such as bacteria, viruses, parasites and fungi. Special interest gained the innate immune system 
that utilizes phagocytosis, antimicrobial peptide (AMPs) production and many other strategies, 
representing the first line of defence. Animals that lack the adaptive arm of the immune system 
completely rely on this ancient type of immunity. As the adaptive immune system evolved in 
vertebrates, all other animals, including invertebrates have to combat infections exclusively with 
their innate immune system. Amongst these animals are all insects as the currently most diverse 
and successful group on earth. One peculiar insect, the fruit fly Drosophila melanogaster is 
widely used as one of the most important model organisms in biomedical research. The identifi-
cation of Toll-receptors as the first pathogen associated molecular pattern receptors [1] 
revitalized the interest in innate immunity, a discovery that was merited by the 2011 Nobel prize 
to Jules Hoffmann. Although innate immunity has been studied in the fly since then, one very 
important aspect of this ancient immune reaction, the epithelial immunity, has almost completely 
been overlooked. In this work, I will focus on one epithelial organ, the larval airway epithelium 
(tracheal system). It is considered to be the largest area exposed to the outer milieu and thus to a 
huge number of pathogens and environmental effectors which are able to induce various inflam-
matory responses. In addition, the Drosophila tracheal system is a good model to study epithelial 
diseases such as asthma and COPD (Chronic Obstructive Pulmonary Disease), because this 
system has a well-understood development and a plastic reaction to different environmental cues. 
One of these common stressors is hypoxia, which animals or tissues are faced with during normal 
life (e.g. by living at high altitude) or during some pathological situations (asthma, stroke and 
cancer).  
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1.1  The Drosophila immune system  
Vertebrates have a highly specific type of immune response (adaptive immune response) that is 
based on the selection of somatically recombined B and T cells. All other animals and plants lack 
this type of immune response. They have fully functional defense strategies without any signs of 
an acquired immune response. Instead they rely on a relatively simple system of inborn immune 
defenses. Interestingly, even vertebrates depend totally on their innate immune system during 
the first few days before developing a specific immune response [2, 3]. The simplicity 
of the Drosophila immune system in combination with its homology to the vertebrate innate 
immune system, made it to a useful model to study the principles of innate immunity. Although 
several important discoveries were primarily made in other insects, the genetic and molecular 
techniques available for Drosophila have been instrumental in the rapid progress of the field 
during the past few years [4]. The immune response in Drosophila is manifested in at least three 
ways: first, a humoral response generates circulating antimicrobial peptides; second, cellular 
response results in phagocytosis and/or encapsulation of the intruder and the third is a phenolox-
idase reaction that deposits black melanin around wounds and foreign objects. The inducible 
antimicrobial peptides are important effectors of the humoral but also of the epithelial response 
[5, 6]. At least, 34 antimicrobial peptides in eight major families are encoded in the Drosophila 
genome (Figure 1). They include broad-spectrum antibiotic peptides such as the cecropins, which 
kill Gram-negative bacteria, Gram-positive bacteria and fungi. They include broad-spectrum 
antibiotic peptides such as the cecropins, which kill Gram-negative bacteria, Gram-positive 
bacteria and even fungi [7].  
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Figure 1: Families of antimicrobial peptides in Drosophila. 
AMPs except the lysozymes, which are expressed constitutively, are induced in infected animals. Most of these 
families have several members, which are encoded typically by small clusters of related genes. The attacins and 
diptericins share similar glycine-rich domains, and drosocin may be related to the proline-rich amino-terminal 
domain in diptericin. Drosomycin belongs to a family of seven very similar peptides [4]. 
 
Other peptides are more specialized, such as the glycine-rich diptericins and attacins, which 
affect growing Gram-negative bacteria, and drosomycin, which kills fungi. The production of 
most of these peptides is triggered by the presence of microorganisms. Within a few hours of an 
infection, these peptides reach micromolar concentrations or higher in the insect hemolymph 
which thus becomes a very hostile environment for the pathogens. 
The cellular response involves circulating blood cells, called hemocytes. At least, three classes of 
hemocytes can be distinguished morphologically: plasmatocytes, lamellocytes and crystal cells. 
Plasmatocytes, the main class of hemocytes, are phagocytically active and take up bacteria and 
other foreign particles. Lamellocytes are produced in a more specialized cellular reaction after 
host infection by larger parasites, which trigger the proliferation and differentiation of hemocytes 
Lysosyme 
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into this second class of cell. The large flat lamellocytes are involved in forming a cellular 
capsule around the parasite. Crystal cells, which are characterized by the presence of a crystalline 
inclusion, contain phenoloxidase and have an as yet unknown role in the pathway that activates 
this enzyme [4]. In fact, the immune defence in Drosophila relies mainly on three major signal-
ling systems, the Toll, IMD and JAK/STAT pathways as described in the following sections. 
1.1.1 Toll Signaling Pathway 
The Toll-pathway of insects has to fulfill two different functions, the patterning of the early 
embryo ensuring the dorso-ventral patterning and to recognize invading microorganisms and 
launching an appropriate immune response. For the latter response, PAMPs of potential patho-
gens have to be recognized and this recognition translated into the expression of e.g. 
antimicrobial peptide genes. Recognition of bacterial products is not direct; it is mediated via a 
cascade present in the hemolymph. Two different types of signals can be recognized, 1) peptidog-
lycans and ß-glucans on one hand and 2) Danger associated molecules on the other hand [8]. 
Whereas the first type of reaction depends on binding of these PAMPs to e.g. soluble PGRPs and 
GNBPs, the latter one activates Persephone, a protease. All Toll-activating pathways converge 
onto spätzle, a soluble cytokine that is cleaved and therewith activated. Activated spätzle in turn 
can than bind to the Toll-receptor and trigger Toll-dependent events in the target organs [8]. This 
type of activation differs substantially from the one observed in mammalian Toll-like receptors 
(TLR). There, a set of more than ten different TLRs recognize different PAMPs, including LPS, 
peptidoglycans, lipoteichoic acid, flagellin or CpG [9]. Activation of these TLRs leads to induc-
tion of antimicrobial peptide genes, cytokines (e.g. IL6), chemokines and maturation of dendritic 
cells [10-12]. A direct link between innate and adaptive immunity is seen in the TLR-induced 
dendritic cell maturation that is required for activation of CD4+, and CD8+ T-cells [12]. Fur-
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thermore, some members of TLRs are directly expressed on T- and B-cells activating cell diffe-
rentiation, proliferation, affecting memory cells and antibodies production [13, 14]. 
Thus, both mammals and invertebrates use the TLRs/Toll pathway to recognize and typify 
invading pathogens, in similar signaling pathways as described in Figure 2 adapted from [2]. 
In Drosophila, signalling from the membrane receptor encoded by the Toll gene activates two 
NF-κB factors, Dif and Dorsal. From these two, Dif is more important for immune responses, 
whereas Dorsal functions mainly in the embryo, where the Toll signaling pathway determines the 
dorsal–ventral polarity [15]. At the resting stage, Dif and Dorsal form inactive complexes with 
Cactus, a Drosophila member of the IκB family of NF-κB inhibitors. Toll signaling results in the 
phosphorylation of Cactus, followed by the ubiquitination and proteasome-dependent degradation 
of this inhibitor. Dif (and Dorsal) then translocate to the nucleus where they participate in the 
transcriptional activation of target genes. 
Numerous gene products mediate the signaling between Toll and Dif and most of them are 
related to factors in the human IL-1 and Toll-like receptor (TLR) pathways. Pelle and Tube were 
identified in early embryonic mutant screens [15], whereas MyD88 and Traf2 were identified 
recently by their similarity to human factors  [16, 17]. No mammalian homolog of Tube has been 
identified, but the other genes all have counterparts in human IL-1 receptor signaling: the kinase 
Pelle corresponds to human IRAK, Drosophila Traf2 to human TRAF6, and MyD88 to the 
human homolog with the same name [4]. 
The final phosphorylation of Cactus is carried out by a kinase that remains unknown. The Droso-
phila IκB kinase (IKK) homolog was first described as a Cactus kinase [18] but is not required 
for the Toll pathway [19]. Instead, it has a vital role in the activation of another NF-κB factor 
Relish [20]. 
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Figure 2: Toll/ TLR (Toll-like receptor) signaling pathway.   
In invertebrates, the Toll pathway is activated by binding to spätzle and downstream activation via dMyD88 
dependent or non-dMyD88 dependent, leading to activation of cactus and subsequent Dif/Dorsal nuclear transloca-
tion and finally upregulation of antimicrobial peptide gene expression. In vertebrates TLRs function as pattern-
recognition receptors of the innate immune system. Their recognition of microbial products leads to the activation of 
the nuclear factor κB (NF-κB) signaling pathway by binding lipopolysaccharide or CD14 (in case of TLR4). Once 
TLR4 is activated, it recruits the adapter protein MyD88, which is associated with the serine–threonine protein 
kinase interleukin-1 receptor-associated kinase (IRAK). IRAK/TRAF-6 activates the IκB kinase 1 (IKK1) and IκB 
kinase 2 (IKK2). These kinases phosphorylate IκB on serine residues, thus targeting IκB for degradation and 
releasing NF-κB, which moves into the nucleus and induces the transcriptional activation of a wide variety of 
inflammatory- and immune-response genes [2]. 
 
The major humoral response of Drosophila to infection is the stimulation of genes encoding 
antibacterial peptides in the fat body, the functional equivalent of the mammalian liver [21]. The 
first evidence suggesting that dorsal or a related gene might be important in the humoral immune 
response was the discovery of κB binding motifs in the upstream regulatory regions of the genes 
encoding the antibacterial agents cecropin, diptericin, and attacin [22-25]. The identification that 
activation of the Toll-signaling pathway induces an anti-fungal response and that animals defec-
tive in the Toll-receptor are more susceptible to fungal infections was the starting point for the 
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rebirth of innate immunity as a major discipline in immunity [1]. This discovery was awarded 
with the nodel prize in medicine to Jules Hoffmann and Bruce Beutler.  
1.1.2  The IMD Signaling Pathway 
Immune deficiency pathway (IMD) is the second signalling pathway that leads to activation of 
NF-κB factors in the fruit fly. In this case the corresponding factors are known as Relish. Within 
seconds after an infection, Relish is cleaved into two parts. The amino (N)-terminal REL-68 
fragment, which contains the DNA-binding Rel homology domain, translocates to the nucleus 
where it binds to κB-like enhancer elements in the promoters of antimicrobial peptide genes. The 
other fragment, REL-49, is IκB-like and remains in the cytoplasm, surprisingly without inhibiting 
the activity of REL-68 [26]. 
Two human Rel factors, p105 and p100, have a compound structure that is comparable to Relish, 
with carboxy (C)-terminal IκB-like domains that are detached by processing. The rapid signal-
dependent cleavage of Relish is, however, very different from the currently established picture of 
p105 and p100 processing, in which the proteasome degrades the IκB-like half of the molecules 
in a constitutive manner. By contrast, Relish processing is proteasome-independent and requires 
the product of the Dredd gene, a member of the caspase family of proteases [26].  
The IMD pathway drives the expression of diptericin and most other antimicrobial peptide genes. 
The signalling pathway shows a high degree of homology between vertebrates and invertebrates. 
The IMD pathway of insects shows congruencies with the tumour necrosis factor receptor 
(TNFR1) cascade [27]. Despite these similarities between the insect and vertebrate innate im-
mune system, recognition of pathogen associated molecular pattern (PAMPs) varies significantly 
between them. The characteristic feature of the humoral response in Drosophila is the synthesis 
and secretion of seven (plus isoformes) types of antimicrobial peptides (AMPs). AMPs are 
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mostly small cationic molecules with high activity against different infections with microorgan-
isms [28-31]. The production of antimicrobial peptides is also an important aspect of host defence 
in vertebrates. Similar to insects, mammals express multiple peptide antibiotics, such as the 
antibacterial defensins, cathelicidins and the antifungal histatin [32]. Genetic analyses have 
further supported the hypotheses that both, the TNF- (mammalian) and IMD- (insects) pathways 
are homologous [33-36] as illustrated in Figure 3. 
 
Figure 3: Schematic representation of IMD/TNF Signal pathway activation.   
The IMD pathway is probably triggered by an interaction between the transmembrane receptor PGRP-LC and 
peptidoglycan from Gram-negative bacteria. Following PGRP-LC activation, the death-domain (DD) adaptor 
protein, IMD, is recruited and binds to Fadd, which interacts with the caspase DREDD (Death-related ced-3/Nedd2-
like protein). DREDD has been shown to associate with Relish. Phosphorylation Relish is in turn responsible for 
activating AMP genes and thus regulating immunity modified from [36]. 
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1.1.3 JAK/STAT pathway 
1.1.3.1 The JAK/STAT-signaling pathway in mammals 
The JAK/STAT signal-transduction cascade was initially defined in mammals and elucidated to 
impact numerous cytokines and growth factor signals [37]. JAKases activated following ligand 
binding and receptor dimerization phosphorylate tyrosine residues in their associated receptors, 
allowing normally cytosolic STAT molecules to anchor onto the receptor complex via their SRC 
homology2 (SH2) domains. The mobilized STAT molecules are themselves activated by JAK-
mediated phosphorylation of an invariant tyrosine residue in their C-terminal region and then 
either homo- or heterodimerize prior to nuclear translocation. Upon translocation into nuclei, 
activated STAT dimers bind to consensus DNA target sites (consensus TTCNNNGAA). In 
mammals, four JAK and seven STAT genes have been identified and additionally more than 30 
cytokines and growth factors have been shown to be part of this signaling pathway [37, 38] . 
1.1.3.2 Structure of the JAK/STAT and the JNK pathway in flies 
Through its role in embryonic segmentation, the JAK/STAT pathway was identified in flies [39]. 
The pathway is mainly composed of four components; the ligand unpaired (Upd), the receptor 
domeless (Dome), the JAK kinase (Hopscotch/Hop), and the STAT transcription factor 
(STAT92E/Marelle). Whereas three different upd genes are present in the fly’s genome (upd1-
upd3), all other components have one representative gene [38] as shown in Figure 4.  
In the airway epithelia, the JAK/STAT-pathways is fully functional in response to pathogens. All 
components of the pathway are present in this tissue, allowing for an organ autonomic response 
of this signaling pathway [40, 41].  
Various studies have been shown that stimulation of the Drosophila immune response activates 
both NF-κB and JNK signaling pathways. Bacterial infection activates also the JNK pathway, 
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by induction of the Drosophila homolog of the mammalian MAPK kinase, TAK1 (transforming 
growth factor β-activated kinase 1), which functions as a Drosophila IκB kinase-activating kinase 
and as the JNK kinase-activating kinase. However, JNK signaling is not required for antimicrobi-
al peptide gene expression but is required for the activation of other immune inducible genes, 
including Punch, sulfated, and malvolio. Apparently, JNK signaling may play a vital role in the 
cellular immune response and the response to stress presumably also including hypoxia [42]. 
 
Figure 4: Overview of the JAK/STAT dependent Drosophila immune responses.  
Upon septic injury or other stressor such as ROS, Upds (e.g. Upd3) occur in the hemolymph and subsequently 
activates JAK/STAT signaling in fat body. These signaling events control the activation of genes coding for e.g. the 
thioester-containing proteins (TEP) and the TOT peptides. The TEP proteins presumably promote phagocytosis, 
whereas the function of the TOT peptides is unknown. Upon wasp parasitization, plasmatocytes spread on the 
surface of the eggs and are thought to send a yet uncharacterized signals to the lymph glands. This signaling event 
triggers massive JAK/STAT-dependent differentiation of lamellocytes in the lymph glands. Upon lymph gland 
dispersal, lamellocytes are released into the hemolymph and encapsulate the wasp eggs. Adapted from [38]. 
1.2 Interconnection between IMD and JNK pathway 
For innate immune responses to infections, regardless if in vertebrates or invertebrates, the JNK 
family of MAP kinases plays a central role in its signal transduction. Activation of JNK conduces 
the regulation of main cellular processes, such as differentiation, apoptosis and directed cell 
movements [43-46]. Recently, a whole-genome RNAi screen utilizing Drosophila S2 cells 
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focused on modifiers of the IMD-pathway, revealed that core elements of the JNK pathway have 
this capacity [43].  
Moreover, Relish-mediated JNK inhibition involves proteasomal degradation of TAK1, the 
MAPKKK responsible for JNK activation in response to LPS. These data conclude that specif-
ic targets of Relish that are induced during immune responses promote ubiquitination of TAK1 
thus blocking the JNK cascade [47]. The fact that cycloheximide and actinomycin D also down-
regulate JNK activity suggests that genes targeted by Relish rather than Relish itself promote this 
interaction, which is depicted in Figure 5.  
 
Figure 5: Activation of the Drosophila IMD/JNK branches in signal transduction. 
Gram-negative peptidoglycan might bind directly to PGRP-LC and -LE, to signal to Imd. Imd regulates at least three 
downstream events. First is TAK1, which then stimulates IKK-dependent cleavage and activation of Relish. Second 
is the FADD–Dredd pathway that also activates Relish; this branch has a negative regulatory loop that involves the 
caspase inhibitor Dnr-1. Third is the activation through TAK1 of the JNK pathway, which regulates early response 
genes, wound healing and melanization. The JNK pathway is also negatively regulated by Relish. The protein level 
of Relish, and thus the responsiveness of the Imd pathway, might also be regulated by an ubiquitin–proteasome 
complex, modified from [48, 49]. 
 
Antagonism between JNK and NF-κB signaling is evolutionary conserved. Inactivation of either 
IKKβ or NF-κB RelA (p65) in mice cells lead to JNK activation in response to TNFα [50]. Various 
studies have identified distinctive molecules as mediators for the NF-κB mediated inhibition of 
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JNK signaling in the TNFα pathway, including XIAP [51], GADD45β [52], and reactive oxygen 
species [53]. In Drosophila, bacterial infection always results in a brief increase of phospho-
dJNK levels that parallels IMD/dJNK pathway activation, while no increase in dreddB118 mutant 
flies could be observed [45]. 
1.3 Epithelial immunity 
Epithelia act as the first line of defense to inhibit bacterial invasion. Epithelial cells are spread 
over different tissues such as the epidermis, the digestive tract (gut), the respiratory system 
(trachea), and the reproductive systems. These tissues are in direct contact with microbes, and 
they function as standard routes of microbial infection [32, 54]. Those strains (transgenes) 
that carry AMP promoter-GFP fusions reveal that AMP genes are expressed in surface epithelia 
locally in a cell- or tissue-specific manner. This expression may be constitutive (e.g., drosomycin 
in the female spermatheca; [32] or inducible (e.g., diptericin or drosomycin in trachea and gut). 
The production of the inducible AMPs is at least partially under the control of the Imd pathway 
as reviewed recently [34]  . 
The major effector system in the intestinal epithelium is depends on the local production of 
reactive oxygen species (ROS). For this, the dual oxidase (Duox) of the host produces hydrogen 
peroxide to kill invading pathogens and an immune-regulated catalase 
seems to abolish the damage to the host tissue [55-57]. Disturbing the redox homeostasis in the 
intestine by knocking out the duox gene led to a highly increased susceptibility to oral bacterial 
infections. These results imply that immune-regulated catalase and Duox activities are important 
for regulating reactive oxygen species levels and therewith protecting the fly against gut infec-
tions [55, 56]. 
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Another aspect associated with epithelial immunity becomes apparent following wounding of 
these structure. Breaking the barrier epithelial activates the cellular immunity to form clots that 
trap microbes and also limit the loss of hemolymph [58]. Various proteins have been identified to 
be entitled making the clot fibers (e.g., hemolectin and fondue, a multidomain protein expressed 
in plasmatocytes). Both proteins are required for melanization but do not disrupt the ani-
mals' viability; proposing that these proteins are necessary for wound healing [58-60]. 
Melanization independent clotting can occur, as pro-phenol oxidase-compromised mutants form 
normal clots [58]. The process of hemolymph coagulation is presumably similar to the production 
of extracellular fibrous traps expressed by mammalian neutrophils after cytokine activation, 
which kills bacteria independently of phagocytosis [61, 62]. 
In Drosophila, like in mammals, the barrier epithelia are in continuous contact with large num-
bers of microorganisms. These surfaces must be governed with competent immunity for 
microbial recognition and defense. For that, the gut and trachea, the two major routes of infec-
tion, are lined with a chitinous matrix [34]. In addition, local production of AMPs and ROS 
provides two complementary inducible defense mechanisms in the gut as shown in Figure 6. 
The response is triggered upon natural infection by Gram-negative bacteria and is mediated by 
the IMD pathway [32, 54]. For example, drosomycin and diptericin are induced in both trachea 
and gut via the IMD pathway in response to local infection by bacteria such as Erwinia carotovo-
ra [41, 63]. The response initially is mediated through the recognition of Gram-negative PGN by 
PGRP-LC [64].  
The second arm of immunity in Drosophila, Toll, is not implicated to be relevant in the local 
immune response [5, 34, 41]. In mammals, pathogen removal depends on production of ROS. In 
fact, balancing between ROS production and elimination seems to be imperative [5, 65]. 
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Figure 6: Gut immune response is composed of two independent pathways. 
Local production of ROS (left) and AMPs (right) provides two inducible defense mechanisms in the gut. ROS are 
produced by the Duox protein and are detoxified by the IRC catalase. Enzymatic assays demonstrated that the PHD 
domain of Drosophila DUOX can transform H2O2 into the highly microbicidal HOCl. AMPs (e.g., Diptericin or 
Attacin) are produced by epithelial cells under the control of the IMD pathway upon recognition of PGN released by 
Gram-negative bacteria. Amidase PGRPs degrade PGN in non-immunostimulatory fragments, thereby reducing the 
gut immune reactivity. Bacteria such as Pseudomonas entomophila secrete an abundant protease (AprA) that 
degrades AMPs and PM, peritrophic matrix [34]. 
 
The Duox proteins belong to a conserved family that contain, an N-terminal extracellular perox-
idase domain (PHD); alongside the NADPH domain; this structure gives it the ability to produce 
ROS in a regulated manner [66].  Duox RNAi flies have not the ability to produce ROS upon 
bacterial infection, indicating that this enzyme is the main machinery of epithelial ROS produc-
tion [56].  
The airway epithelium of the fly reacts different to bacterial infection if copmpared with the 
intestine. In the latter one, ROS production appears to be the most relevant type of reaction 
whereas the conventional IMD-mediated response dominates in the airways [41, 65].  
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This difference might be attributed to the presence of the endogenous microbiota in the intestine 
that has to be secured and not erased by a strong IMD-dependent immune reaction. In the airway 
this restriction of the response is not necessary. 
1.4  Reaction to hypoxia 
Tissues suffer depletion in oxygen delivery at high altitude or during certain pathological condi-
tions, such as cancer, myocardial infarction and stroke. Various strategies have been branched out 
to maintain survival of the organism in such low oxygen conditions; nevertheless, tissue tolerance 
to hypoxia is distinctive between the different species. The molecular mechanisms underlying 
survival in those intensive hypoxic conditions are not fully understood at the moment [67]. 
Oxygen plays a multitude of essential roles in eukaryotic cellular physiology (e.g., metabolism 
and energy production). Since its critical role in cell survival, eukaryots have evolved different 
mechanisms to cope with low oxygen levels (hypoxia). One of the most important ways of 
adaptation to hypoxia is the differential regulation of specific gene sets [68]. By varying the 
amounts of transcripts for various genes, cells are able to alter quantities of assorted proteins, and 
by doing so, change their physiology in ways that allow them to better cope with hypoxia. This 
hypoxia-induced transcriptional modulation is accomplished through the action of hypoxia-
responsive transcription factors, proteins that are directly involved in regulating the quantities of 
transcripts that are produced from specific sets of genes. The best-characterized transcription 
factor in response to hypoxia is the Hypoxia Inducible Factor-1 (HIF-1) [69, 70]. HIF-1 is a 
heterodimeric transcription factor composed of dual subunits known as HIF-1 α and HIF-1β. 
HIF-1 β is a protein that is dominantly present in many cells, and dimerizes with several other 
transcription factors other than HIF-1α in order to regulate transcription of diverse cellular 
responses ranging from reaction to environmental toxins, up to neural development [71]. HIF-1β 
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is essential for the function of HIF-1 as a hypoxia responsive transcription factor, but plays a minor 
role in the regulation of its activation. Otherwise, HIF-1α is a protein that is the major sensor for 
cellular oxygen levels. This regulation is the main core in the regulation of HIF-1 activity [70]. 
Under normal levels of oxygen (normoxia), HIF-1α is hydroxylated at a proline residue by an 
enzyme known as HIF-1 Proline Hydroxylase (HPH). When HIF-1α is hydroxylated, it is recog-
nized by the Von Hippel Lindau tumor suppressor protein (VHL), which facilitates the 
ubiquitination and rapid proteasomal degradation of the HIF-1α. Upon hypoxia, HIF-1α is not 
degraded, translocates to the nucleus and dimerizes with HIF-1β. The dimeric HIF-1 transcription 
factor activates the expression of its target genes, by binding to DNA sequence motifs characte-
rized by the core sequence 5'- TRCGTG-3'. These elements are present, often in clusters, near 
genes that are regulated by HIF-1 under hypoxia. Large number of genes has been identified as 
HIF-1 targets in mammalian and other model systems. HIF-1 is responsible for the transcriptional 
upregulation of genes such as erythropoietin (EPO), and Vascular endothelial growth factors 
(VEGF) which increase oxygen delivery to hypoxic areas by stimulating production of red blood 
cell, and the recruitment of blood vessels respectively in mammals as shown in Figure7 [72]. In 
the fruit fly Drosophila melanogaster, HIF-1 regulates HPH, providing a feedback mechanism by 
which HIF-1 activity is attenuated during hypoxia [73]. Other studies showed that in Drosophila, 
HIF-1 directly regulates the transcription of the Heat shock factor (HSF), a transcription factor 
that activates the expression of heat shock protein genes [68]. The full complement of HIF-1 
regulated genes in Drosophila has not been cataloged yet. However, another factor that has been 
shown to regulate gene expression during hypoxia is the Forkhead transcription factor Fox-
O.  Basically, FoxO activity is repressed by insulin signaling, its activation 
results in stimulation sets of genes’ serving to cope with stress conditions (e.g., starvation). 
Interestingly, increase in FoxO activity is leads to an increased longevity in Drosophila melano-
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gaster and Caenorhabditis elegans.  Several genes involved in reactive oxygen species detoxifi-
cation have been described as FoxO targets, as well as other genes involved in protecting cell 
from other stressors [74]. Recently, FoxO factors have been shown to activate gene expression in 
response to hypoxia in human cells [75]. 
Another transcription factor that has been shown to activate gene expression in response to 
hypoxia is the nuclear factor kappa-B (NF-κB). As a central transcriptional regulator of the 
inflammatory response in mammals, NF-κB has been characterized [76]. NF-κB can be activated 
through a wide range of stimuli, including bacterial antigens, pro-inflammatory cytokines, 
oxidative stress, and ultraviolet radiation. As mentioned before, in Drosophila, there are three 
NF-κB proteins, Dorsal (Dl), Relish (Rel), and Dorsal-related immunity factor (Dif) [77]. Vari-
ous studies have shown that NF-κB is activated by hypoxia, the mechanism by which this occurs 
is unclear [78, 79]. Hypoxia can induce the production of Nitric Oxide (NO) and of other reactive 
oxygen species (ROS) [80, 81]. Although we are not sure regarding the underlying mechanism, 
we and others have observed multiple targets of Rel, as well as Rel itself being transcriptionally 
regulated by hypoxia in Drosophila [82]. 
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Figure 7: Tissue responses to Hypoxia/ischemia. 
The alpha subunits of HIF are hydroxylated at conserved proline residues by HIF prolyl-hydroxylases, allowing their 
recognition and ubiquitination by the VHL ubiquitin ligase, which labels them for rapid degradation by the protea-
some [83]. This occurs only in normoxic conditions. In hypoxic conditions, HIF prolyl-hydroxylase is inhibited 
results in stabilizing HIF-1α (pseudohypoxia). HIF-1, when stabilized by hypoxic conditions, upregulates several 
genes to promote survival in low-oxygen conditions. These include glycolysis enzymes, vascular endothelial growth 
factor (VEGF), which promotes angiogenesis and activate other responsive genes. Modified from [84] 
 
1.5 The airway epithelium 
1.5.1 Anatomy of the human lung 
Lungs are the organs of respiration in humans. Humans have two lungs, with the left being 
divided into two lobes and the right into three lobes. Together, the lungs contain approximately 
2400 km of airways and 300 to 500 million alveoli, having a total surface area of about 70 m2 in 
adults — roughly the same area as one side of a tennis court [85]. Furthermore, if all of the 
capillaries that surround the alveoli were unwound and laid end to end, they would extend for 
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about 992 km. Each lung weighs 1.1 kg; therefore making the entire organ about 2.2 kg. Oxygen 
enters the respiratory system through the mouth and the nose to the trachea, which splits into two 
smaller tubes called the bronchi. Each bronchus then divides again forming the bronchial tubes. 
The bronchial tubes lead directly into the lungs where they divide into many smaller tubes, which 
connect to tiny sacs called alveoli. The average adult's lungs contain about 600 million of these 
spongy, air-filled sacs that are surrounded by capillaries. Each lung consists of approximately 300 
million alveoli which closely form each other recumbent the surface required for the gas ex-
change of 80-100 m² [86]. The inhaled oxygen passes into the alveoli and then diffuses through 
the capillaries into the arterial blood. Meanwhile, the waste-rich blood from the veins releases its 
carbon dioxide into the alveoli. The carbon dioxide follows the same path out of the lungs during 
exhaling. 
 The diaphragm is a sheet of muscles that lies across the bottom of the chest cavity. As the 
diaphragm contracts and relaxes, breathing takes place (Figure 8).  
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Figure 8: Structure of the human lung.  
A) Schematic representation of the human lung, with its two lobed lung and lower airways that are dichotomously 
branched. B) Representation of a contrast right lung with his bronchial tree. C) Alveolar ducts of the human lung, 
which open in the Alveolar sacs (alveoli). D) Semi-thin section of a human lung alveolar sac. Modified from [86] 
                                                     
1.6  Structure of the fruit fly’s larval tracheal system  
 The larval tracheal system of Drosophila is a widespread, bilaterally symmetric tube system that 
permeates the entire body of the larva. It consists in late larval stage of about 10,000 intercon-
nected tubes and two pairs of respiratory openings (spiracles) on the front or rear end of the 
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larva. Small structures embedded in skin folds (stigma), these stigmas with short movable and 
lockable structures are dorsally located in the larval tracheal system as shown in figure 9.  
 
Figure 9: Tracheal system of larval stage of Drosophila melanogaster [87]. 
 
The both primary branches run parallel in a stereotype way through the entire body of the larva, 
they split in nearly every segment to the inner and outer secondary branches. While the inner 
secondary branches are very short and only extend dorsally, the outer secondary branches pulled 
deeply throughout of the whole body of the larva on both sides of the body. These secondary 
branches are branched into hundreds of fine tertiary branches (tracheoles), which with their 
terminals in direct contact with the organs. While the ramifications of the primary and secondary 
branches in the larval tracheal system are formed during embryonic development in a stereotype 
way, the making of the tertiary branches in the larva are variable and dependent on the oxygen 
content of the surrounding tissue. Thus, especially in low-oxygen areas of the body cavity dense 
networks of tertiary branches can be observed [87, 88]. The main task of the larval tracheal 
system is the efficient supply of the body with oxygen. The oxygen is passively transported 
through the two respiratory openings included in the body of the larva. Usually, the larvae keep 
the posterior part in direct contact with the oxygen milieu while the anterior part is used for 
feeding from the first larvae to late third stage (L3) of their lives. The oxygen passes through the 
primary and secondary branches to the tertiary, where the direct diffusion to the tissue taken 
place. Since the whole of the tracheal epithelium is layered, it can be assumed that even in the 
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field of primary and secondary branches, the oxygen exchange to body tissues can take place. 
Branches of the larvae tracheal system are lined with a thin cuticle made of chitin. It stabilizes the 
trachea with cuticular bars (Taenidia) and prevents its collapse. In the tertiary branches, this 
cuticular structure is reduced to a minimum level which allow maximum oxygen supplementation 
to the organs [89, 90]. 
1.7 Physiology and the plasticity of the airway system 
Various stimuli can affect physiology and development of  animals, such as nutrient availability, 
and oxygen tension. Different adaptations occur to maintain organismal survival in these distinct 
milieu conditions, implies upregulation or repression of supportive genes maintaining the cellu-
lar homeostasis. Reactions that can be seen in response to hypoxia may include enhancment of 
oxygen transport from respiratory surfaces to tissues or reduction of the metabolic process. In 
many lower species, enhanced tolerance to hypoxia results from a marked and controlled reduc-
tion of metabolism [91, 92]. Mammals adapt to the low oxygenation through a wide range of 
reactions like, increase of heart and respiratory frequency, synthesis of more red blood cells, 
vasodilatation, and angiogenesis. The latter process (angiogenesis) is a developmental process 
that is common to many physiological and pathological conditions such as formation of the 
placenta, endometrial growth, wound healing, ischemic heart disease, stroke, and cancer [93, 94]. 
This includes the budding of new fine capillaries from the basically existing blood vessels. This 
happens when hypoxia seeking cells secrete angiogenic growth factors, mainly the Vascular 
Endothelial Growth Factor (VEGF), which binds its receptors on the endothelial cells of blood 
vessels [70]. VEGF transcription in hypoxic cells is mainly depended on the nuclear translocation 
of Hypoxia-Inducible Factors (HIFs) [93, 95]. 
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In Drosophila melanogaster, HIF is also a bHLH-PAS heterodimer in which Similar (Sima) is 
the oxygen-regulated α subunit [96, 97], whereas the constitutive β subunit is named Tango [98, 
99]. The circulatory system of insects is rudimentary, and nearly without function [100]. In fact, 
tissue oxygenation is achieved directly through the tracheal system, a network of ramified, 
interconnected, and progressively narrowing air-containing epithelial tubes [101, 102]. By mid-
embryogenesis stages, the Drosophila tracheal system develops from ectodermal primordia, in a 
process that largely depends on guided cell migration [103]. Branchless (Bnl) is an FGF homolo-
gue expressed in the outer-tracheal cell subset is recognized by the FGF receptor breathless (Btl) 
which is located on the tracheal cell surface [104, 105]. Upon Bnl/Btl binding, a new cluster of 
branches is formed. The third instar larvae have a complete tracheal system with only few cells 
able to respond to low-oxygen tension -the terminal cells. They can differentiate and make new 
small outer projections called terminal branches [106] in a process analogous to mammalian 
angiogenesis [107]. In addition, Bnl protein accumulation in hypoxia and ectopic activation 
results in tracheal chemoattraction and new branches formation. Therefore, the angiogenic-like 
response of the Drosophila tracheal system is activated by hypoxia-inducible expression of Bnl in 
nontracheal cells, which promotes the formation of new terminal ramifications [70, 108]. 
1.8 Aim of the study 
Hypoxia is associated with a great variety of diseases including inflammatory diseases of the 
airways such as asthma or COPD. Although much is known regarding the mechanisms underly-
ing these diseases, the contribution of hypoxia to the pathological phenotype is not well 
understood.  This is true all the more regarding the role of the airway epithelium itself. Therefore, 
the major aim of this study is to characterize yet unknown effects of hypoxia on the airway 
epithelium and to unravel the underlying molecular mechanisms. For this, I used the fruit fly 
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Drosophila melanogaster as a model. A special focus was on those aspects of hypoxia that are 
related to disease phenotypes including inflammation and remodeling of the airways. Finally, this 
work should increase our understanding regarding the physiological adaptation of the airway 
epithelium to hypoxia and their role during pathogenesis. 
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2. Materials and Methods 
2.1  Materials used in this study 
2.1.1  Hypoxia chambers 
 Experimental chambers (26 cm x 16 cm x 16 cm) were specially designed and supplied with 5% 
O2 balanced with N2 as depicted in figure 10. Humidity was maintained by passing the gas 
through water prior to entry into the chambers. The flow speed was monitored with a 565 Glass 
Tube Flow meter (Concoa, Virginia Beach, VA, USA), and the O2 level within the chamber was 
periodically tested with a Diamond General 733 Clark Style electrode (Diamond General Devel-
opment Corp., Ann Arbor, MI, USA). 
 
Figure 10: Photograph of hypoxia Chambre. 
Home-designed hypoxia chamber  made of polyethylene and titied with two screws, and supplied with input/ouput 
sources. The system qligned with 565 Glass Tube Flow meter  to control the gas flow, standard treatment condition 
was used during the whole experiments. 
2.1.2  Standard fly food 
Ninety gram of agar was added to eight liters of aqua bi-distilled, and boiled until agar is dis-
solved. Then, 165 g brewer's yeast, 615 g cornmeal and 1 l syrup were added to 3.3 liters of aqua 
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bi-distilled, and added to the soluble agar. It is boiled for 15 minutes and stirred sporadically. 
After cooling down to 55 °C, 200 ml of a 10% nipagin solution were added. 
2.1.3 Fly Strains and Genetic Crosses 
Stocks were raised on standard cornmeal-agar medium at 25°C in a 12h/12h light dark cycle. 
w1118 served as the wild-type control; controls in transgenic experiments are usually based on 
lines under study crossed with w1118 [109]. The transgenic strains drosomycin::gfp (drs), pppk-
Gal4, btl-gal4, UAS-dFoxO-gfp, foxo21, foxo24, relishE38, UAS-sima-RNAi, UAS-PGRP-LCx, 
UAS-GFP, UAS-Pi3K92E(DN) , UAS-P53(DN), Atg5-RNAi and LDH-Gal4/UAS-nGFP were 
used and have been described elsewhere [32, 110-115]. 
2.1.4 Oligonucleotides used for RT and qRT-OCR 
Primer Sequence 
OdT-T7I GAGAGAGGATCCAAGTACTTATACGACTCACTATAGGGAD
AT(25)V 
CF-SP6rG1 AGCGGCCGCAGATTTAGGTGACACTATAG ArGrGrG 
OdT T7II GAGAGAGGATCCAAGTACTAATACGACTCACTATAG 
CF-Sp6-PCR CAG CGG CCG CAG ATT TAG GTG ACA CTA TAG 
attacin_FOR CACAATGTGGTGGGTCAGG 
attacin_REV GGCACCATGACCAGCATT 
cecropin_FOR AAGATCTTCGTTTTCGTCGC 
cecropin_REV GTTGCGCAATTCCCAGTC 
defensin_FOR TTTTGCTCTGCTTGCTTGC 
defensin_REV ACATGATCCTCTGGAATTGGA 
diptericin_FOR CGCAATCGCTTCTACTTTGG 
diptericin_REV TCCCTGAAGATTGAGTGGGTA 
drosocin_FOR CCATCGAGGATCACCTGACT 
drosocin_REV CTTTAGGCGGGCAGAATG 
drosomycin_FOR GAGGAGGGACGCTCCAGT 
drosomycin_REV TTAGCATCCTTCGCACCAG 
metchnikowin_FOR TCTTGGAGCGATTTTTCTGG 
metchnikowin_REV TCTGCCAGCACTGATGTAGC 
Rpl13_For CGTGGTTTCACCCTGGAG 
Rpl13_Rev TGGTCTTGGCGAAGTTGG 
2.1.5 Devices buffers, antibodies and materials 
Prouct name Manufacturer 
Water bath Thermostat Eppendorf AG (Hamburg) 
Agarose Electrophoresis Chamber Biometra GmbH  (Göttingen) 
My Cycler PCR Bio-Rad Laboratories GmbH (München) 
Vortex Genie 2 Scientific Industries, Inc (New York, USA) 
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NanoDrop® (ND-1000) Peqlab (Erlangen) 
Glas homogenizer (konisch 1 ml) VWR International GmbH (Darmstadt) 
StepOne user QRT-PCR Applied Biosystems 
Olympus SZX12 stereomicroscope Oberkochen 
Plastic material Sarstedt AG & Co (Nümbrecht) 
Glycogen 5mg/ml Merck (Darmstadt) 
Sodium acetate  Merck (Darmstadt) 
6X Loading Dye MBI Fermentas GmbH (St.Leon-Rot) 
MnCl2  Sigma-Aldrich GmbH (Taufkirchen) 
dNTPs set Promega (Mannheim) 
Superscript IIITM Reverse Transcriptase  Invitrogen Life Technologies (Karlsruhe) 
RNase inhibitor (40U/µl) Applied Biosystems (Darmstadt) 
Taq DNA Polymerase (5 U/µl) Invitrogen Life Technologies (Krlsruhe) 
SAWADY PWO DNA polymerase  Peqlab Biotechnologie GmbH (Erlangen) 
GeneRulerTM 1 kb DNA ladder MBI Fermentas GmbH (St.Leon-Rot) 
JETQUICK PCR Purification Spin Kit Genomed (Löhne) 
10x Advantage PCR Buffer BD Biosciences Clontech (Heidelberg) 
SciHypChamber Scienon (Berlin) 
GenePixTM4000B scanner Molecular Devices GmbH (München) 
NanoDrop® (ND-1000) Peqlab (Erlangen) 
LiferSlip(22x60) Implen GmbH (München) 
PBS, 0.15 M pH7.4 0.14 M sodium chloride (NaCl); 2.7 mM  (KCl;8.1 
mM (Na2HPO4); 1.5 mM KH2PO4; adjust the pH to 
7.4 HCl 
0.3M NaHCO3 pH9 Dissolve 2.52 g of NaHCO3 in 80ml of water; adjust 
to pH9 with 0.3 M Na2CO3; bring up to 100ml with 
water 
10x TBE Buffer 108 mg Tris base; 9.3 mg Na4EDTA; 55 mg Boric 
acid; fill up to 1 liter with ddH2O 
20X SSC  pH 7 175 g NaCl; 88 g Na3citrate 2xH2O and adjust to pH 
7 with 1M HCl, fill up to 1l with ddH2O 
Rat monoclonal α-GFP Santa Cruz Biotechnology, Inc. cat: sc-101536 
Rabbit polyclonal α-dfoxo Cosmo Bio Co., LTD. (Tokyo, Japan) 
Mouse monoclonal α -Relish DSHB; anti-relish-C 21F3 (University of Iowa, 
USA) 
Mouse monoclonal α-MMP1 DSHB; 3B8D12 (University of Iowa, USA) 
Secondary Dylight-594 JacksonImmunoResearch (Dianova, Hamburg)  
Secondary Dylight-488 JacksonImmunoResearch; (Dianova, Hamburg) 
 
2.2  Methods 
2.2.1  Hypoxia treatment 
Third instar larvae were collected from each genotype and placed in separate vials containing 
standard Drosophila medium for each hypoxia experiment. Six replicate population were col-
lected for each genotype. After a 24-hour recovery period following counting, three of the vials 
for the wild type strain and each mutant were placed in a sealed chamber at room temperature 
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that was then flushed with a mixture of 5% O2 and 95% N2 (hypoxia). The three other vials for 
each respective genotype were placed in an identical chamber containing normal atmospheric 
oxygen concentrations (normoxia). The flies were incubated in the hypoxia and normoxia 
chambers for four hours, following which they were rapidly removed and takeout the trachea for 
downstream preparations. 
2.2.2 Fly construction 
The yw67c23;pkk4-gal4;+/+[113], w*; P[UAS-PGRP-LC.x]2; P[Dipt2.2-lacZ]3, PGRP-LC1 
ca1/TM6B, Tb1(Bloomington stock center), w[*]; P-foxo21/foxo21 homozygot and y[1] w[*]; 
foxo w24/ TM6B, Tb, Hue (gift from Marc Tatar) were crossed to double balancer w-; Sp/CyO 
P[elav-lacZ, ry+]; TM2/TM6 B P[ubx-lacZ, w+]( gift from Tobias Storck). First generation of 
each line was crossed vis-a-vis and sorted according to the balancer inserted; the detailed proce-
dure listed in the supplementary data (Fig.38). The homozygous line was sorted and used for 
downstream experimental procedures. 
2.2.3 The binary GAL4/UAS-Expression system  
The Gal4/UAS-expression system in Drosophila allows the study of ectopic expression of genes 
in different spatial and temporal expression patterns [116]. The binary system comes originally 
from the yeast Saccharomyces cerevisiae and passes of the transcription factor Gal4 and the 
accompanying Gal4-binding sites UAS (upstream activating sequence). It is activated in the 
yeast by presence of galactose and activates the transcription of genes, which are necessary for 
the galactose metabolism. In the fly the binary Gal4/UAS-expression system the GAL4 gene is 
placed under the control of a native gene promoter, or driver gene, while the UAS controls 
expression of a target gene. GAL4 is then only expressed in cells where the driver gene is usually 
active. In turn, Gal4 should only activate gene transcription where a UAS has been introduced. 
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For example, by fusing a gene encoding a visible marker such as GFP (Green Fluorescent 
Protein) the expression pattern of the driver genes can be determined as depicted in figure 8. 
GAL4 and the UAS are very useful for studying gene expression in Drosophila as they are not 
normally present and their expression does not interfere with other processes in the cell. For 
example, Gal4/UAS-regulated transgenes in Drosophila have been used to alter glial expression 
to produce arrhythmic behavior in a known rhythmic circadian output called pigment dispersing 
factor [117]. However, some research has indicated that over-expression of GAL4 in Drosophila 
can have side-effects, probably relating to immune and stress responses to what is essentially an 
alien protein [118].  
The GAL4-UAS system has also been employed to study gene expression in organisms besides 
Drosophila, such as the African clawed frog Xenopus [119] and zebrafish [120]. The 
GAL4/UAS system is also utilized in Two-Hybrid Screening, a method of identifying interac-
tions between two proteins or a protein with DNA. 
A big disadvantage of the Gal4/UAS-expression system lies in its lack of temporal inducibility. 
Because numerous GAL4 drivers are expressed already during the very early phases of embryo-
nic development and during different developmental stages, a specific activation of the 
expression system is nearly impossible to a certain developmental stage of the fly. Thanks to the 
development of the expression system TARGET that is dependent on temperature shifts (tem-
poral and on the regional level gene expression targeting) exists the possibility to handle this 
lacking temporal variability of the Gal4/UAS system [121]. The expression system TARGET 
comes like the Gal4/UAS system from the yeast and is based on the availability of a temperature-
sensitive Gal80 protein. If one integrates ubiquitously expressed  Gal80 (driven by the tubulin 
promotor) into a Gal4/UAS background, one sets up in the F1 generation a TARGET system, 
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which is depending on the surrounding temperature. At the repressive temperature (19°C), Gal80 
completely represses Gal4. Shifting the temperature to 29-30 °C inhibits Gal80, thus removing 
the repressive effect from Gal4 and expression starts in the Gal4 dependent manner [122].  
 
Figure 11: The binary Gal4/UAS-Expressions system of D. melanogaster.  
Through two separate transposase insertions transgenic fly strains expressing either Gal4-cell and / or developmen-
tally (Driver strain) or a gene of interest under UAS control are made. The resultant F1 generation is expressing the 
gene of interest in the pattern of Gal4 expression. Adapted from [123]. 
 
2.2.4 Infection Experiments 
For infection experiments, early 3rd instar larva was confronted with the gram-negative bacte-
rium Erwinia carotovora according to protocols used in [5]. Briefly, overnight cultures of the 
bacterium were centrifuged, concentrated (OD600 = 100) and mixed with banana at a ratio of 
1:1. Larvae was allowed to feed for 6 h on these bacteria, subsequently, they were allowed to 
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feed for another 6 h on normal medium, and the trachea were prepared out of the animals and 
used for further experiments. 
2.2.5   Immunohistochemistry and Microscopy 
Third instar larvae (early 3rd instar larvae or young adults, 6-8 days after an imaginal moult) 
were dissected inside-out in PBS with 4% paraformaldehyde and fixed for 20 minutes. The 
trachea were washed for six times 10 minutes with 0.1% Triton X-100, 10% NGS in PBS and 
then incubated with the primary antibody overnight. After washing for 6 times for 10 minutes 
with 0.1% Triton X-100 in PBS the secondary antibody was applied for 2 h. All antibodies were 
diluted in the respective washing buffer. In all tissue samples, nuclei were stained with diamidi-
nophenylindole (DAPI) and mounted with 80% glycerol in PBS. Anti-dFoxO antibodies was 
diluted 1:1000 (Cosmo Bio Co., LTD), anti-MMP1 1:50 (DSHB) and anti-Relish 1:100 from 
(DSHB) were used in this experiment. Microscopic analysis was performed either with an 
Olympus SZX12 stereomicroscope equipped with an epifluorescence support or with a Zeiss 
Axio Imager Z.1 microscope. 
2.2.6  Total RNA isolation 
The total RNA extracted from the trachea of the 3rd larvae instars was performed using RNAmag-
ic solution as follows: Take 20 pairs of dissected 3rd instars larvae trachea in 100µL of RNA 
magic; homogenize flies using a homogenizer for 30sec, then incubate the homogenized material 
at RT for ≤ 5min. Fill up to 1 ml with RNA magic, add 200µL of chloroform and vortex vigo-
rously for 15-30 sec and centrifuge at 12,000 x g for 20 min at 4
o
C. Isolate the upper, aqueous 
layer and precipitate with 1 volume isopropanol, centrifuge at maximum speed for 20 min at 4
o
C. 
Materials and Methods 
32 
 
Finally, wash the RNA pellet with 1000 µL ice cold 75% ethanol, dry and resuspend in 52 µl of 
nuclease free water 
2.2.7  Preparation of complementary DNA (cDNA) 
cDNA is a DNA copy, synthesized from mRNA. The enzyme used is reverse transcriptase an 
RNA-dependent DNA polymerase isolated from a retrovirus (AMV or MMLV). As with other 
polymerases a short double-stranded sequence is needed at the 3' end of the mRNA, which acts 
as a start point for the polymerase. This is provided by the poly (A) tail found at the 3' end of 
most eukaryotic mRNAs to which a short complementary synthetic oligonucleotide (oligo dT 
primer) is hybridized (polyT-polyA hybrid). Together with all 4 deoxynucleotide triphosphates, 
magnesium ions and at neutral pH, the reverse transcriptase synthesizes a complementary DNA 
on the mRNA template. The protocol is put into practice as follow, 3µl of total RNA was added 
in a 200 µl sterile tube on ice, mixed gently with 1 µl Oligo(dT7 I) ,1µl SP6rG1 primers (0.5 
µg/µl) 0.25µl MnCl2 (40mM), 1 µl of DTT and spun down for 5 seconds in a microfuge. The 
mixture was incubated at 70 °C for 5 min and the tube placed on ice. Then following compo-
nents were added: 2 µl of 5 x reaction buffers, 0.5 µl of RibolockTM Ribonuclease inhibitor (20 
U/µl) and 1 µl of 10 mM dNTPs mix. I mixed gently and incubated at 37°C for 5 minutes. In the 
last step I added 1 µl of Primescript RTase 200u/µl from TaKaRa (200 U/µl) and incubated the 
mixture at 42 °C for 60 min. The reaction was stopped by heating at 70 °C for 10 min. The 
newly prepared cDNA could be used directly in PCR reaction or frozen by –80°C freezer. 
2.2.8  Preparation of PCR 
The PCR reaction was performed by adding 5 µl 10X advanced buffer, 2µl of dNTPs, 1 µl of 
OdT7II and SP6PCR or sense/antisense specific primer in case of global amplification or specif-
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ic gene amplification, respectively. 40µl of water and 0.5 µl of Taq/Pwo mixture (19:1) were 
added. Mix all previous components and finally add 2µl of sscDNA into a final volume of 50µl. 
I mixed the sample by pipetting up and down, loaded it in a thermocycler at 94°C, followed by 
the next program using: Initial denaturation at start: 94°C for 2 min; denaturation at  94°C for 1 
min; annealing at 72°C for 30 seconds; elongation at 59°C for 2 min with 5 seconds time increas-
ing every cycle. The steps 1 to 3 were repeated 28 times and at end the sample was heated at 
72°C for 5 minutes to allow complete elongation of all DNA products and then chilled at 4 °C.  
2.2.9  Agarose gel electrophoresis of DNA 
Agarose gel electrophoresis is a method used in biochemistry and molecular biology to separate 
DNA or RNA molecules by size. This is achieved by moving negatively charged nucleic acid 
molecules through an agarose matrix with an electric field (electrophoresis). Shorter molecules 
move faster and migrate further than longer ones. To pour a gel, agarose powder was mixed with 
electrophoresis buffer (TBE) to the desired concentration (e.g. 1 % agarose solution), then heated 
in a microwave oven until it is completely melted (10 min, 400 W). After cooling the solution to 
about 60 °C, ethidium bromide was added to the gel. Then it was poured into a casting tray 
containing 2 combs, one at the middle of the gel and the other at one side, about 5 mm from the 
end of the gel and allowed to solidify at room temperature or in a refrigerator. After the gel had 
solidified, these combs were removed, using care not to rip the bottom of the wells. The gel, still 
in its plastic tray, was inserted horizontally into the electrophoresis chamber and just covered 
with buffer. Samples containing DNA mixed with loading buffer were then pipetted into the 
sample wells (30 µl), the lid and power leads were placed on the apparatus and a current was 
applied (100 V, 400 mA). DNA migrates towards the positive electrode. When adequate migra-
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tion had occurred (usually after 30-35 min), DNA fragments were visualized by using the gel 
documentation camera (Molecular Imager Gel Documentation, Bio-Rad, München).  
2.2.10 Purification of PCR-Products  
The PCR products were purified using a JETQUICK PCR Purification Spin Kit 250TM according 
to the manufacturer’s protocol with small modifications; Step 1). Sample Prepared by adding 400 
µl of solution H1 to 100 µl PCR assay and mix thoroughly. Step 2) Load the mixture from step 1 
into the prepared spin column. Centrifuge at >12,000 x g for 1 min. Discard the flow through. 
Step 3) Column washing; re-insert the spin column into the empty receiver tube and add 500 µl 
of reconstituted solution H2. Centrifuge at >12,000 x g for 1 min. Discard flow through and 
place the JETQUICK column back into the same receiver tube. Centrifuge again at maximum 
speed for 1 min. Step 4) DNA Elution Place the JETQUICK spin column into a new 1.5 ml 
microfuge tube and add 80 µl TE buffer directly onto the center of the silica matrix of the 
JETQUICK spin column. Centrifuge at >12,000 x g for 2 min. Repeat the last step 3 times at 
65°C. 
2.2.11 Concentration of PCR products  
To 240 µl of purified DNA I added 24 µl of 3 M Sodium acetate pH 5.5 and 600 µl of 100% 
EtOH. Then, I mixed thoroughly and centrifuged for 20 minutes at maximum speed, washed two 
times with 75% ice cold EtOH. Subsequently, the pellets were dried and resuspended in 12 µl of 
TE buffer. 
2.2.12  Labeling of total RNA for microarray hybridization 
High quality RNA may also be obtained from whole larvae or adult flies, but as with any tissue 
sample a secondary cleanup may be required. At present we are labeling 600µg of RNA per 
Materials and Methods 
35 
 
sample. The amount of RNA to be labeled can be reduced, but correspondingly the hybridization 
signal will also decrease.  
2.2.13  Synthesis of Non-radioactively Labelled RNA Probes (cRNA) 
The reaction based on the method of in vitro cRNA-synthesis [124]. In our laboratories we use 
Ambion MEGAscript®Kit (Cat #AM1330, AM1333, AM1334, and AM1338). According to the 
manufacturer’s protocol with small modifications in the volume of materials, for one sample, the 
following components were combined on ice and in the following order. Then the reaction was 
incubated at 37°C for 4hrs I used to take 2 µl dATP; 2 µl dTCP; 2 µl dGTP; 1 µl dUTP; 1.5 µl 
aa-UTP;  4.5 µL H2O;  2 µl 10X  reaction buffer;  3 µl template and 2µl  enzyme mix to make 20 
µl per sample. 
2.2.14 Recovery of amplified RNA  
The Phenol: chloroform extraction and isopropanol precipitation is the most rigorous method for 
purifying transcripts. It will remove all enzyme and most of the free nucleotides from MEGA 
script®Kit reactions. Since the RNA is precipitated, this method can also be used for buffer 
exchange. To each sample add 1 ml of RNAmagic and 200 µl of chloroform, and mix thoroughly 
by vortexing. Precipitate the RNA by adding 1 volume of isopropanol and mixing well, then chill 
the mixture for at least 15 min at –20°C. Centrifuge at 4°C for 15 min at maximum speed, wash 
with 75% ice cold ethanol, carefully remove the supernatant and resuspend the dried pellet in 
required volume of nuclease free water. 
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2.2.15 Quantification of reaction products using the NanoDrop device 
The NanoDrop® ND-1000 Spectrophotometer (NanoDrop Technologies) was used to determine: 
260/280 ratio, to assess total RNA and aRNA purity; 320/550 and 320/650 ratios, to evaluate 
Cy3 and Cy5-labelled aRNAs, respectively. 
2.2.16 Labeling of aminoallyl amplified RNA (aaRNA) 
Remove the Cy-Dyes from the fridge and put in the room temperature until it reaches ambient 
temperatures, add 36 µl of fresh DMSO. For 3.33 µl of amplified aa-modified cRNA, added 6.67 
µl of 0.3 M NaHCO3 pH 9 and 10 µl 1mM Cy3-dCTP or Cy5-dCTP. Mix very well by gently 
pipetting up and down and keep in the dark for 90 minutes. 
2.2.16.1  Precipitation of aminoallyl Amplified RNA 
Fill up to 1 ml with RNA magic and add 200 µL of chloroform, then vortex vigorously for 15-30 
sec and spin at maximum speed for 20 min at 4oC. Transfer the clear, aqueous phase to a new 
tube, precipitate by adding an equal volume of ice cold isopropanol with gentle invert 7-10 times 
to mix and centrifuge at 21,000 x g for 15 min at 4oC. Wash with 1000 µl of 75% ice cold EtOH 
and elute the dried pellet in 11 µl ddH2O. 
2.2.16.2 Probe Hybridization to Microarray Chips 
For hybridisation I used the microarray chips produced by Canadian Drosophila Micoarray 
Centre (http://www.microarrays.ca/index.html). Gene expression analysis was performed by 
using the Drosophila OLIGO 14k_version1 gene chip (Canadian Drosophila Microarray Center, 
University of Toronto, Canada). This chip contais 48 subarray, each contais 336 spot. Total of 
16.128 spots are available on each chip. 14,444 are transcript-specific oligonucleotide and the 
other controls to lapse. All transcript-specific spots are presented as duplicates.  
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I prepare a new coverslip by immersing in ice-cold Ethanol, wash the hybridization chamber 
with  ddH2O and leave it to dry in the room teperature. The hybridization solution for all arrays 
used has the following recipe: Per 54 µl DIG Easy Hyb I added: 
                                        2.88 µl 10 mg/ml yeast tRNA 
    2.88 µl 10 mg/ml salmon sperm DNA 
Adjust the probes to 200 pmol each, mix with the buffer and take 40 µl of the previous mixture 
into a 500 µl tube; incubate at 65 °C for 10 minutes to denature the probe. Set the coverslip on a 
raised surface over the microarray slide and pipette the denatured probe between them avoiding 
any bubbles introducing. Close the hybridization chamber, enclosed with Aluminum foil, and 
incubate in a 42 °C hybridization oven for 16-18 hours. 
2.2.16.3  Washing of the microarray slides 
Carefully remove the cover of the chamber and the cover slip. In a Falcon tube that is wrapped 
with aluminum foil, and filled with 1X SSC insert the slide, stir for 90 minutes. Wash 15 minutes 
2 times with 1X SSC, 0.1 % Triton x-100 at 60°C, and with 0.1 X SSC, Triton x-100 at 37 °C for 
10 minutes 2 times. Immerse the slide in a coplin jar filled with 0.1 XSSC for 30 seconds and in 
ddH2O for 10 seconds. Dry the rest of water with a stream of nitrogen. 
2.2.16.4  Image acquisition and analysis 
The slides were scanned by using the GenePixTM4000B scanner (Axon Instruments, Molecular 
Devices, München, Germany), the based scanner capable of multi-channel fluorescence scan-
ning, was used to analyze and scan the slides at the two wavelengths to detect emission from 
both dyes. Random areas of the slide were examined to determine proper exposure for each 
channel. The images were analyzed photometrically by the GenePix Pro 6.0 from Axon Instru-
ments/Molecular Devices Corp to identify the arrayed spots and to measure the relative 
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fluorescence intensities and ratios for each spot. The signal intensity was calculated as the mean 
pixel value minus the local regional background. Gene expression could then be observed as an 
increase or decrease in gene expression relative to the fly base information. 
2.2.16.5  Bioinformatics tools and analysis 
Gene expression analysis was performed by using the Drosophila OLIGO 14k_version1 gene 
chip (Canadian Drosophila Microarray Centre, University of Toronto, Canada). The slides were 
scanned by using the GenePixTM 4000B scanner (Molecular Devices, München, Germany). For 
spot finding and generating preliminary results, files of the scanned images were analyzed using 
GenePixPro version 6.0, whereas data normalization, quality assurance and control, filtering and 
clustering were carried out with Acuity 4.0 (Applied Biosystems, Germany). Venn diagram 
analyses were performed with the online tool Venn diagram generator of the pangloss laboratory 
(http://www.pangloss.com/seidel/Protocols/venn.cgi) 
2.2.17 Relative quantification of qRT-PCR data 
In order to perform relative quantification, all Ct values must be transformed into relative quanti-
fication data, expressed as 2-ΔΔCt [125]. Crossing threshold data can be imported into Excel from 
real-time PCR platforms and subsequent analyses can be performed in Excel. During 2-ΔΔCt 
analysis, each sample (run in triplicate) was treated separately. The mean Ct of each sample and 
standard deviations were calculated. Standard deviations should be within 1 Ct, and if there were 
outliers (>2 standard deviations), these data points were removed from the analysis. The means 
of each sample were used for analysis. The first step of analysis (ΔCt) was to normalise all the 
samples with respect to the least expressed sample, thus subtracting the highest Ct value from the 
Ct value of each sample. In this step, the least expressed sample had a ΔCt value of 0 and all the 
other samples had negative values. Hence all data was expressed relative to the expression of the 
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least expressed gene. The second step was to perform the function (ΔCt sample - ΔCt reference), which 
gives a ΔΔCt value. The third step was to calculate 2-ΔΔCt, which yielded the expression ratio (as a 
positive integer) for each individual sample. After performing the 2-ΔΔCt calculation for each 
sample, we calculated the means for each group in addition to determining the standard deviation 
and standard error of the mean (SEM) thus providing a relative expression ratio (in arbitrary 
units) and variation between ratios. The expression ratio data were amenable to statistical tests 
such as analysis of variance (ANOVA) to the expression ratios.  
2.2.18  Statistical analysis 
Kaplan-Meier survival analysis was used to compare lifespan between groups; all other data 
were analyzed using student t-test or one-way ANOVA and graphed using GraphPad Prism 5.0 
(GraphPad Software, Inc., San Diego, CA). 
Results were expressed as group mean ± SEM. Difference in means were considered statistically 
significant when p < 0.05, unless otherwise stated. Analyses of qRT-PCR data were done using 
the Relative Expression Software Tool 2009 (REST2009), a Qiagen freeware. 
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3. Results 
3.1 The response to hypoxia is time dependent 
Hypoxia experiencing tissues show different types of responses, both at the morphological and 
the transcriptional level. The response to hypoxia is dose-dependent, meaning that increasing the 
time of treatment leads to higher overall treatment doses. To specify the most effective dose of 
hypoxia, which gives the optimal response while keeping most animals alive I did time course 
experiment with various time point and various concentrations of oxygen (O2 1%, 5% and 0% O2 
- nitrogen only). Animals were confronted with these different doses of hypoxia for 0 hr, 1hr, 2 
hr, 4 hr, 6hr, 8 hr 16 hr and 24 hr respectively, as shown in Figure 12. All experiments were 
performed with Drosophila third instar (L3) larvae and the matching controls (21% O2).  
 
Figure 12: Time courses of hypoxia experiments.  
Schematic diagram represents the periods of hypoxia treatment used in my experiments. 
 
After the end of the experimental time, the animals were placed on 1XPBS and the trachea were 
prepared manually followed by mRNA isolation to quantify the drosomycin gene expression 
using qRT-PCR. I found that in cases of N2 only (severe hypoxia) most of the animals died after 
one hour of treatment, thus I excluded treatment with N2 for all future experiments. A very 
similar result was found in the case of 1% O2, and I considered this also as very severe hypoxia 
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leading to severe damage and finally to death. Drosomycin expression increased after 1 hr of 
hypoxic treatment and reached its maximum after 4 hr and then declined gradually (figure 13). 
 
Figure 13: Hypoxia was applied for different periods. 
Drosomycin mRNA levels were quantified at different time points (0, 1, 2, 4 and 24 hr) in hypoxia (5% oxygen) 
using wild-type animals (w1118). The yellow column show the control samples; blue are those held in 5% oxygen. 
 
3.2 Induced expression of drosomycin during hypoxia 
Drosomycin is an inducible antifungal peptide of 44 amino acids initially isolated from bacteria-
challenged Drosophila melanogaster. Using the drosomycin-gfp [yw (P(w-, drom-gfp)D4, P(ry+, 
dipt-lacZ)(162:7)2]  as well as six other antimicrobial peptide-gfp reporter lines showed that only 
drosomycin-gfp is activated upon  hypoxia  in the airway of larvae and adults as depicted in Figure 
14. 
            Results 
 42
 
Figure 14: Induction of drosomycin-gfp expression upon hypoxia. 
Hypoxia treatment of a drosomycin reporter (drom-gfp) induced expression of gfp in the airway epithelium only (A-
E). In the overview (A); expression is confined to secondary and terminal branches of the airway system (yellow 
arrows), whereas the major trunks show no or little expression (red arrows). At a higher magnification (B), expres-
sion in especially secondary branches and terminal cells is even more evident. Using the same line, we could also 
observe the hypoxia-induced expression of the drosomycin reporter in the adult tracheal system (C-E). At low 
magnification, the peripheral tracheal system is visible through the cuticle (yellow arrows, C). At higher magnifica-
tion, tracheal structures directly next to the spiracular openings (D) and within the legs (E) are easily visible. 
 
3.3 Hypoxia induced structural changes in the airway epithelium 
Upon mild hypoxia (5% O2), an interesting phenomenon was observed. The thickness of primary, 
secondary and tertiary airway branches was significantly increased (Figure 15 C, D bottom 
panel). If compared with control regions (control: Fig 15 A and B upper panel), I was able to 
quantify this effect as the difference between both experimental groups as shown in Figure 15E. 
These results are in line with previous observation where animals were confronted with the 
bacteria Erwinia carotovora. They also show a remarkable increase in the thickness of the airway 
epithelium [65].  A comparable morphological modification was not observed in control animals, 
indicating that it represents a direct response to the strong and prolonged activation of stress 
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relevant systems. The general organization of the airways as a single cell-layered epithelium is 
not affected, because even in those parts of the airways, in which we observe this type of epi-
thelial thickening, cell nuclei are organized in rows along the airway. In addition, animals 
expressing GFP as a marker in their airways (btl-gal4 X UAS-gfp) that experienced hypoxia 
show a high difference in the morphology of their terminal structures (figure 16). This indicates 
that hypoxia can induce morphogenesis of this subset of tracheal cell by increasing their number 
of branches in case of low oxygen. 
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Figure 15: Changes in the morphology of the airway epithelium following hypoxia. 
The upper panels show the primary (A) and secondary branches (B) of the trachea in normoxic condition with 
normal (thin) epithelium, while the lower panels show the primary (C) and secondary (D) branches of the tracheal 
system under hypoxia. B) Measurements of the primary secondary and tertiary tracheal branches, in normoxia (black 
bars) or hypoxia (gray bars). All values represent the means ± SD (*** p<0.0001). 
 
 
 
Figure 16: Structural changes of the airway epithelium following hypoxia treatment.  
Terminal branches of the animals carrying the construct Btl-gal4 X UAS-gfp following hypoxia were photographed. 
Animals under normoxia in the upper panel (A-C) show the normal trachea architecture.  Upon hypoxia extensive 
changes in the number of terminal branches were observed in the lower panels (D-F). A, D GFP channel, B, E DAPI 
channel, C, F overlay. 
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3.4 Translocation of HIF-1 upon hypoxia 
For the design of a new Hypoxia Responsive Elements (HRE) reporter, the mammalian lactate 
dehydrogenase A (LDH-A) gene, which is hypoxia responsive and well conserved in flies was 
selected [115]. The mammalian LDH-A hypoxic enhancer includes two HREs separated by an 8-
bp spacer and a cyclic AMP responsive element (CRE) located 16 bp further downstream. Both 
HREs and the CRE consensus sequences have been shown to be necessary for strong hypoxic 
induction in mammalian cells [115, 126]. Using an LDH-Gal4/UAS-nGFP reporter strain that 
induces nuclear expression of GFP under transcriptional control of the murine LDH-A enhancer 
[115], I could show that this reaction induces a highly reproducible hypoxic response primarily in 
the airway epithelium as depicted in Figure 17. This implied that the observed response of total 
larvae to hypoxia may reside primarily in the airway epithelium as a dominant response target for 
hypoxia.  
 
Figure 17: HIF nuclear translocation upon hypoxia treatment. 
Expression of the LDH-Gal4/UAS-nGFP in normoxia and hypoxia of early third instar larvae. These larvae were 
subjected to a brief period of mild hypoxia (4h, 5% oxygen). Nuclear expression of GFP was observed in the airway 
epithelium only (red arrows). Background staining of the intestine is due to auto-fluorescence of ingested material. 
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3.5 dFoxO activation following hypoxia 
To identify the underlying mechanism of induced drosomycin expression, I used transgenic 
animals, where XFP tagged transcription factors (UAS-relish-yfp, UAS-dorsal-gfp, UAS-dif-cfp 
[127], and UAS-foxo-gfp are ectopically expressed in the airways (driven by pkk4-Gal4, a 
tracheal epithelium specific driver line) [113] and subjected them to hypoxia. Neither Relish or 
Dif nor Dorsal showed any nuclear translocation following hypoxia (Fig. 18 A, B; It displayed is 
only UAS-dorsal, both other experimental setups yielded identical results). Under normoxic 
conditions, dFoxO-GFP is localized in the cytoplasm of the airway epithelial cells (Fig. 18C). In 
contrast, we observed an almost complete translocation of dFoxO following hypoxia (Fig. 18D, 
E). Using specific antibodies to dFoxO (GST-dFoxO) from Cosmo Bio Co., LTD, I observed a 
very similar reaction to hypoxic conditions. As observed for the expression of the antimicrobial 
peptide drosomycin, the reaction starts at the most terminal branches of the tracheal system and 
reactions in the major branches are seen only in few animals at later phases of the treatment. 
Even after the hypoxic treatment ended, dFoxO-GFP stayed for a certain time (usually more than 
one hour) in the nucleus before re-entering the cytoplasm. The time before re-entering the cytop-
lasm depended on the period of hypoxia, meaning that the longer the hypoxic treatment, the 
longer stayed dFoxO-GFP in the nucleus after return to normoxic conditions. 
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Figure 18: Role of transcription factors for the response to hypoxia.  
Animals expressing GFP-tagged transcription factors were used for all experiments. Dorsal-gfp, either under 
normoxic conditions (A) or hypoxic conditions (B) didn’t show any induced translocation into the nuclei of airway 
epithelial cells. Animals expressing foxo-gfp in the airway system also show a cytosolic expression during normoxia 
(C), whereas those subjected to hypoxia show a clear translocation (D, E). Fig. D shows an overview of a complete 
animal, whereas E shows an isolated trachea. 
 
3.6 Hypoxia-induced AMP gene expression 
To demonstrate the immune response of the tracheal system in response to hypoxia, we used the 
w1118 animals as wild-types to quantify the expression levels of antimicrobial peptide genes 
(AMPs). In this experiment, which the animals confronted with hypoxia (5% O2) were compared 
to its parental control at normoxic condition (21% O2). We analyzed the immune response of 
whole larvae using RT-qPCR, and found that  the expression of cecropin, attacin, drosocin and 
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drosomycin were upregulated upon hypoxic treatment while the other three AMP genes mechni-
kowin, defensin and diptericin were downregulated as depicted in figure 19.  
 
Figure 19: Antimicrobial peptides relative expression during hypoxia. 
 3rd instar larvae of wild-type flies (canton-S) were either subjected to hypoxia (red bars) or held under control 
conditions (black bars) and relative transcript levels of the antimicrobial peptide genes indicated were quantified 
using qRT-PCR. (Each experiment was performed at least three times in duplicate; * means p<0.05, data kindly 
given from K. Uliczka). 
 
3.7 Induced expression of AMPs is dFoxO dependent 
To dissect the molecular mechanism underlying the immune response to hypoxia, I used mutants 
defective in either the IMD-signalling pathway or those devoid of functional dFoxO proteins to 
quantify the regulation of drosomycin, as the most reliable readout, following hypoxia. IMD-
deficient mutants, which are defective in the sole pathway of the fly’s innate immune system 
converging onto activation of NF-κB factors operative in the airway epithelium [32, 41, 65], 
show a slightly reduced, but nevertheless, significant upregulation of drosomycin expression 
following hypoxia (represented  in Figure 20). In addition, knockdown of SIMA, which is part of 
the HIF-machinery, does not impair this response completely, indicating that the hypoxia-
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dependent increase in drosomycin expression does not depend on HIF-1 signaling. In contrast, 
animals defective in dFoxO (foxo21/foxo24 transheterozyotes) show no upregulation of drosomy-
cin expression in response to hypoxia treatment, indicating that dFoxO is essential for this 
response (Fig. 20). Together, these data show that dFoxO can activate AMP expression indepen-
dently of the NF-κB-dependent innate immune pathways. 
 
Figure 20: Analysis of the hypoxia induced immune response in the airway epithelium. 
Quantitative real-time PCR using isolated airways from control animals (held under normoxia) and those that were 
subjected to hypoxia (4h, 5% oxygen). Values are means of at least three independent experiments. Mean control 
values (normoxia) were set as 1. Mean values ± S.D. are given. 
 
To evaluate the possibility if dFoxO can directly induce drosomycin expression, I analysed the 
putative drosomycin promotor region for dFoxO binding sites in silico. This motif binding 
analysis for different genes on the promoter region of drosomycin showed that dFoxO has nine 
binding sites with the consensus sequence (gggctggggg) while there is no binding site for the 
Forkhead gene FKH (tctggccatg). In addition, the terminal JNK-pathway products Basket 
(gaccggaacg) and Puckered (ccgcaaagtc) have three and four binding sites, respectively. Conco-
mitantly, the IMD core factor Relish has three motif binding sites (atcggcgccc) and finally insulin 
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receptors (InR) were defined by the consensus (gtcttcactg) has two binding sites as depicted in 
Figure 21. These data demonstrate that dFoxO-activation would be sufficient to induce drosomy-
cin expression. 
 
Figure 21: Motif binding sites on the drosomycin promoter region.  
Bioinformatic analysis for the promotor region of drosomycin for various relevant transcription factors 
showed that different binding sites were identified for NF-κB (blue) and insulin responsive elements (green). On the 
other hand, there are no binding sites for the Drosophila fork head-A family member dFoxA (Orange; not shown), 
while the other representative family member dFoxO (red bars) is the most dominant one. 
As shown above, the upward bars indicate forward orientation; downward bars indicate reverse orientation. Analysis 
was done using the RSAT website (http://rsat.ulb.ac.be/). 
3.8 Hypoxia induced immune responses are presumably mediated by 
JNK/dFoxO signaling 
The JNK-pathway is activated by different types of stressor (e.g. UV irradiation). Previous 
studies using cell cultures suggested that JNK signaling might play an important role in the 
control of apoptosis after DNA damage [128-130]. To test the hypothesis whether JNK signaling 
is required for inducing drosomycin expression in the Drosophila trachea upon hypoxia, third 
instar larvae carrying a  dominant negative basket allele (bskDN) were exposed to mild hypoxia 
(5% O2), subsequently trachea were dissected and stained with the anti-dFoxO antibody. Com-
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paring the nuclear translocation of dFoxO of those animals treated with hypoxia with their 
matching controls (21% O2) showed no dFoxO translocation into the nucleus upon hypoxia in 
those animals expressing BasketDN as shown in Figure 22. 
 
Figure 22: Nuclear translocation of dFoxO depends on JNK-signaling.  
The upper panel A-C shows the pkk4-GAL4 X UAS-bskDN either under normoxia and stained with anti-dFoxO 
(green) and anti-mmp1 antibodies (red) respectively. The comparison with those animals that experienced hypoxia 
(bottom panel D-F) revealed no translocation for dFoxO while induced expression of mmp1 gene can be observed. A, 
D, anti-dFoxO - green, B, E, DAPI - blue, C, F merge + anti-MMP1 – red. 
 
To confirm whether the JNK signaling activity can stimulate dFoxO in vivo, an additional JNK 
signaling output is expression of the puckered gene. Puc-GAL4 thus serves as a marker for JNK 
activation. Puckered-GAL4 (PucE69) animals were treated with hypoxia as previously and the 
level of gfp expression was monitored. The activation of the puckered promotor was clearly 
obvious if compared to those animals held under normoxic conditions (Figure 23). 
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Figure 23: Activation of the JNK-pathway monitored by a puckered-Gal4 marker. 
The pucE69 allele was crossed to UAS-GFP. The upper panel showed the trachea of the animals held under normox-
ia(A-C, white arrows). Upon hypoxia (4hrs at 5% O2) gfp was expressed more strongly indicating activation of 
puckered expression in the airway epithelium (D-F; yellow arrows). A, D, GFP – green, B, E, DAPI – blue, C, F, 
merge.  
 
3.9 dFoxO defective animals are less resistant to hypoxia 
Performing life span assays is among the most powerful ways to elucidate the effect of a certain 
mutation at the animal level. In order to overcome technical problem I used second instar larvae 
for the survival assay. Twenty first instar larvae from both strains (w1118 and dFoxO defective 
mutants).  Animals were transferred into special small vials (6 cm x 2 cm) supplemented with 1 
cm of standard cornmeal media and allowed them to recover for twenty-four hours before using 
them for assays. Both strains were subjected to hypoxia (5% O2) by placing them into the hypox-
ia chambers. 
Different time points were chosen to monitor the larval health and counting the fraction of 
animals still alive. Survival rates were quantified at least three times independently. At 5% O2 
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dFoxO mutant larvae have a significantly decreased survival rate in comparison to wild-
types. All dFoxO defective animals were dead after 16h, whereas wild-types survived up to 24h 
(figure 24).  
 
Figure 24: Predictive analysis of dFoxO mutant resistance to hypoxia.  
Survival assay of w1118 under normoxic conditions (♦ blue) and hypoxia (■ Green). dFoxO transheterozygotes foxo21/24  
represented by (▲ red) under hypoxia, data of normoxic mutant dfoxo is not represented because it has the same 
values as wilde type.  
3.10 Hypoxia-induced transcriptional regulation in dFoxO defective 
animals 
For these experiments, both, w1118 as well as transheterozygotes foxo21/24 were subjected to 
hypoxia. Following manual dissection of the trachea, this material was used as probes for DNA-
microarray analyses. Transcripts were identified either as being induced or repressed following 
hypoxia. Data analyses were done using Acuity 4.0 Software (Applied Biosystems) and revealed a 
total of 1298 and 1041 transcripts as being induced or repressed following hypoxia. 426 genes 
were identified as significantly upregulated (±1.5 fold) in wild type animals while 106 genes in the 
mutant strains. I analyzed the expression of each of these genes by hierarchical clustering (Figure 
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25). Interestingly, dFoxO mutants exhibit a lower difference in hypoxia-induced genes that were 
regulated if compared with wild-type flies.  
 
Figure 25: Hierarchical clustering of hypoxia in wild type and dFoxO mutant.  
Hierarchical clustering of hypoxia modulated transcripts with significantly perturbed expression levels in wild type 
and mutant strain. Rows represent the average expression levels of transcripts from 3 biological replicates for the 
strain indicated in each column. 
 
In order to identify immune-relevant genes among the regulated ones, I used Venn diagram 
analyses with a comprehensive list of immune relevant genes (Lemaitre lab – 
http://lemaitrelab.epfl.ch/page-7757.html) as depicted in figure 26 and table 1. 
 
 
Figure 26: Venn-diagram analysis of wild type and dFoxO. 
Venn diagrams comparing either up- or downregulated genes of wild-type flies (left), or dFoxO defective mutants 
(right) with the comprehensive list of immune relevant genes.  
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Table 1: List of immune relevant genes regulated upon hypoxia in wild-type and dfoxo21 mutant 
animals. 
 
Gene ID NAME SYMBOL 
Upregulated immune  relevant  genes in the dfoxo21 mutant strain 
CG14401 - CG14401 
CG31741 - CG31741 
CG7227 - CG7227 
CG9928 - CG9928 
Upregulated immune  relevant  genes in the wild-type strain 
CG10697 Dopa decarboxylase Ddc 
CG11159 - CG11159 
CG18108 Immune induced molecule 1 IM1 
CG31764 virus-induced RNA 1 vir-1 
CG4261 Helicase 89B Hel89B 
CG4432 Peptidoglycan recognition protein LC PGRP-LC 
CG4437 Peptidoglycan recognition protein LF PGRP-LF 
CG7496 PGRP-SD PGRP-SD 
CG7798 - CG7798 
CG8502 Cuticular protein 49Ac Cpr49Ac 
Counterpart upregulated genes in both, wild-type  and dFoxO21strain 
CG10563 lethal (2) 37Cd l(2)37Cd 
CG10747 - CG10747 
CG12667 - CG12667 
CG12732 - CG12732 
CG12820 Diacyl glycerol kinase Dgk 
CG14303 - CG14303 
CG17387 - CG17387 
CG17648 - CG17648 
CG32392 - CG32392 
CG32975 nicotinic Acetylcholine Receptor al-pha34E nAcRalpha 34E 
CG33125 - CG33125 
CG33180 Ranbp16 Ranbp16 
CG33255 - CG33255 
CG7200 - CG7200 
CG7236 - CG7236 
CG7257 - Rpt4R 
Common upregulated genes in immune  relevant  genes, wild-type and dFoxO21 strain 
CG7228 Peste pes 
Downregulated genes in wild-type  and dFoxO21 strain 
CG10171 - CG10171 
CG10513 - CG10513 
CG11209 pickpocket 6 ppk6 
CG11278 Syntaxin 13 Syx13 
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CG11686 - CG11686 
CG12072 Warts wts 
CG14117 - CG14117 
CG14395 - CG14395 
CG14506 - CG14506 
CG1801 - CG1801 
CG2973 Cuticular protein 23B Cpr23B 
CG31292 - CR31292 
CG32709 - CG32709 
CG3611 - CG3611 
CG4221 - CG4221 
CG4271 - CG4271 
CG4780 Membrin membrin 
CG5185 Twin of m4 Tom 
CG6463 - CG6463 
CG7049 - CG7049 
CG7861 tubulin-specific chaperone E tbce 
CG8884 Synapse-associated protein 47kD Sap47 
CG9023 Drip Drip 
CG9030 - CG9030 
CG9682 - CG9682 
Downregulated immune  relevant  genes in the dfoxo21 mutant strain 
CG11313 - CG11313 
CG1697 rhomboid-4 rho-4 
CG1851 Ady43A Ady43A 
CG4144 Gram-negative bacteria binding protein 2 GNBP2 
CG7016 - CG7016 
CG9186 - CG9186 
Downregulated immune  relevant  genes in the wild-type strain 
CG1358 - CG1358 
CG13641 - CG13641 
CG13795 - CG13795 
CG15829 - CG15829 
CG16713 - CG16713 
CG31509 Turandot A TotA 
CG5909 - CG5909 
CG7417 TAK1-associated binding protein 2 Tab2 
CG9434 Frost Fst 
CG9441 Punch Pu 
Counterpart  downregulated genes between immune  relevant  genes,wild-type and the 
dFoxO21  mutant strain 
CG14841 - CG14841 
Commonly regulated genes of  wild-type upregulated genes and  dFoxO21 downregu-
lated genes. 
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Figure 27: Analysis of regulated immune relevant genes. 
Venn diagram analyses to compare the downregulated genes of wild-types with the upregulated genes of the 
dFoxo21 mutant strain and vice versa. Analyses showed that a very small number of commonly regulated genes. 
 
 
Gene functional annotation clustering showed higher indicative upregulation for immune respon-
sive genes in the wild type in comparison to a relatively lower term-significance in case of 
dFoxo21 mutant strain as shown in figure 28. 
CG17816 - CG17816 
CG39784 - CG39784 
CG5006 Odorant receptor 33c Or33c 
CG8580 Akirin akirin 
CG8874 Fps oncogene analog Fps85D 
Commonly regulated genes in downregulated genes in wild-type and upregulated 
genes in dFoxO21  
CG6937 - CG6937 
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Figure 28: Cluster image of enriched genes within the different categories.  
(■ Green) is the corresponding gene-term association positively reported while (■ black) is the corresponding gene-
term association not reported yet.Upper panel showed the relevant immune genes represented in response to hypoxia 
in the wildtype animals while the lower panel represent the dfoxo21 knockout animals. 
 
Using FatiGO analysis for GO terms and pathways (KEGG), using a Fisher's exact test to com-
pare the significant over-representation of annotations to the complete Drosophila genome [131]. 
This analysis showed a relevant upregulation for the glycerolphoslipid metabolic pathway 
followed by immune responsive genes (see table 2) in case of upregulated genes in wild-type 
animals, while no significance was found for dfoxo21 defective animals as shown in Figure 28. 
3.11 Transcriptional regulation of Dm-mmp1, dfoxo and relish 
The matrix metalloproteinase MMP-1 is implicated to be relevant for various aspects of the fly’s 
biology. In previous studies, an induction of mmp1 expression following infection of the airways 
has already been shown (Christina Wagner, pers. commun.). In line with these earlier observa-
tions, I observed an induction of mmp1 expression when larvae of wild-type animals (w1118) were 
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treated with hypoxia (4h, 5% O2). Furthermore, dFoxO protein levels were increased after 
hypoxia. This experiment showed that both genes, dfoxo and relish were induced upon hypoxia. 
Bioinformatic analyses of the promoter region of the mmp1 gene (defined from -20800: -20570 
with a total size of 231 bp) showed that this promotor contains only two consensus sites for 
dFoxO (CACAGGCGCCAC and CATCGGCGCC, a single Cis-Regulatory Element enriched 
Region (CRERs) of dFoxO in the region from -197 to -186), while consensus sequences for 
Relish (GGCGCC) are not present as shown in Figure 29. 
 
Figure 29: Regulations of dFoxO and Relish by hypoxia.  
The upper panel shows wild-type animals w1118 under normoxic conditions (A-C) or hypoxic conditions (D-F). The 
tracheae were stained with anti-dFoxO (A, D; green) and anti-relish (B, E; red), merge (C, F). The immunohisto-
chemical studies showed the induction of the dFoxO and relish proteins upon hypoxia. The panel G represents a 
motif analysis of dFoxO and relish binding sites on the mmp1 promotor. 
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3.12 Stress triggers mmp1 expression 
Previous study showed a notable increase of mmp1 mRNA levels upon H2O2 treatment [132]. 
Here, I activated mmp1 expression using the TARGET system [121]. The TARGET system uses 
a temperature-sensitive Gal80 to inhibit Gal4 at the permissive temperature. Combining this with 
the Gal4-UAS system in flies allows for temporal control of transgene expression. Temporal 
control is important for these experiments, as a constitutive expression of mmp1 results in lethali-
ty. Upon shifting animals from 18°C to 30°C, the mmp1 expression is induced (Figure 30). In 
addition, tracheal rearrangements, such as thickening of the airway epithelium can be identified. 
 
Figure 30: Ectopic activation of mmp1mutant strain. 
Ectopic activation of mmp1gene in the trachea by crossing the temperature sensitive tracheal driver line PKK4-
GAL4/GAL80 with mmp1-overexpression line (UAS-mmp1). Nuclear translocation of dFoxO (A` red arrows) and 
mmp1 expression (B` yellows arrows) has been observed in animals shifted to 30°C from 18°C. The left panel show 
the parental control of this crossing at 18°C; no translocation were observed (A-C ;White arrows). mRNA levels of 
mmp1 gene were quantified using the qRT-PCR as shown in figure D. 
 
Additionally, animals overexpressing mmp1 are crawling out of the lawn, a similar behavior as 
seen in animals experiencing hypoxia. Furthermore, mmp1 downregulation is necessary for 
tracheal remodeling as well as for removal of the primary cuticle of the trachea after moulting. 
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Upon mmp1 overexpression, the airway keeps the old cuticle within the new one, which may lead 
to severe problems during gas exchange along the animal body. 
3.13 Infection induces Dm1-MMP activity and AMPs gene expression. 
Recently it has been shown that infection with Erwinia carotovora can induce antimicrobi-
al expression via a unique mechanism [41, 63, 65].  
 
Figure 31: Remodeling of airway epithelia following infection.  
Experiencing animals with infection (Erwinia carotovora) induces the remodeling of tracheal airways. Upon 
infection the thickeness of the airway epithelia increased in comparison to control epithelia as shown in A (narrated 
with red arrow). At least three experiments were used to quantify this phenomena as depicted in B for the primary 
and the secondary branches. All values represenad as means ± SEM  
 
3.14 IMD pathway activation during hypoxia 
To analyze by which mechanisms different challenges like hypoxia and infection direct mmp1 
overproduction I performed ectopic activation experiments. To unravel the role of Relish in 
regulation of mmp1 expression, I stimulated the IMD-pathway in the Drosophila airway epithe-
lium with hypoxia (5% O2) for four hours while the control animals settle down in (21% O2). 
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Figure 32: dFoxO and IMD pathways parallel modulate mmp1 expression.  
Crossing of the tracheal driver PKK4 GAL4, whether with the dFoxOTM or UAS-PGRP-LC and further staining with 
anti-dFoxO (green) and anti-MMP1 (red) have been used. In the panels from A-D` can show the expression of both 
dFoxO (A, E, E’) and MMP1 (C, G, G’) proteins in the dFoxOTM::PKKGAL4 upon hypoxia in comparison 
its parental control under normoxia. In the panels E-H`, the expression of mmp1 proteins in the 
UASPGRPLC::PKKGAL4 upon hypoxia in comparison its parental control under normoxia has been, on the other 
hand; no dFoxO protein could be detected (E and E`). DAPI staining (B, E, E’) used to show the localization of 
nuclei within the cells. 
 
A weak signal of MMP1 in the trachea of control animals was detected, while the signal in-
creased dramatically in those animals that were treated with hypoxia as shown in Figure 32. 
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These data conclude that the IMD pathway can regulate mmp1 expression. Nevertheless, IMD 
pathway is not able to mediate the cell stress in a direct way, but it triggers the dFoxO using an 
additional cascade, which can stimulate the immune response and deteriorate the cell stress. This 
may be taken as a primary phase until the other cascades can be activated to realize the maximum 
protection for maintaining cell survival. 
3.15 Dm-mmp1 confers an additional immune response 
In these experiments I used the TARGET system [121] to induce mmp1 expression. We maintain 
the mutant control animals at 18°C and upon shifting to 29°C the system is activated, and we can 
monitor the changes in the activated system. Activation of TARGET system by shifting to 29°C 
leads to slight upregulation of  dfoxo (1,4 folds). Unexpectedly relish was downregulated six fold 
as shown in figure 33A. 
 
I also determined the gene expression of AMPs in ectopically activated mmp1 in the airway 
epithelia. Defensin, drosocin, drosomycin and metchnikowin are significantly upregulated, 
whereas attacin, cecropin and diptericin are not (Fig. 33B).  
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Figure 33: Additional immune activation may be induced by mmp1 regulation. 
qRT-PCR analysis of mRNA levels for antimicrobial peptide genes, dFoxO and relish. In this experiment, the 
TARGET systems were used to activate the F1 generation from crossings of the tracheal driver pkk4GAL4/GAL80 
with the line overexpressing mmp1 (UAS-mmp1). Panel A shows the induction of dfoxo and relish, while B 
represents the expression change for the AMP genes. Blue bars are from non-activated animals (set as one), red bars 
from those activated by shifting them to 29°C. 
 
3.16 Dm-MMP1 production is JNK-dFoxO dependent 
To explore the link between JNK signaling, dFoxO and their function for mmp1 expression, the 
protein expression of MMP1 and dFoxO in JNK dominant-negative lines (JNKDN) were conse-
quently determined. Confronting animals with hypoxia (5% O2) for four hours reveals that 
neither dFoxO, nor MMP1 protein levels were upregulated in those animals carrying the basket 
dominant negative isoform. Taken these observations together assume that JNK cannot directly 
induce the AMPs expression, but activate a downstream target dFoxO controlling diverse cellular 
reaction. 
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Figure 34: Induced expression of Drosophila mmp1 is JNK/dFoxO dependent.  
The dominant negative basket allele (bskDN) was crossed to the tracheal driver pkk4-GAL4. The larvae were treated 
with hypoxia (5% O2, A’-D’) or maintained under normoxia (21% O2, A-D). Arrows show the location of nuclei. 
Staining with anti dFoxO (green, A, A’), DAPI (blue, B, B’), anti MMP1 (red, C, C’) and the merge of A-C (D) and 
A’-C’ (D’). 
3.17 dFoxO independently activates Dm-mmp1 expression 
In addition to of the previous results, I wanted to elucidate if dFoxO can induce mmp1 expression 
without other inputs. For this purpose, Pkk4-Gal4 in a dfoxo21 background were crossed to UAS-
PGRP-LC in a dfoxo24 background. As controls, dfoxo-/- defective lines were crossed to each 
other. Animals were analysed for expression of mmp1 or dfoxo by using immunohistochemistry. 
As expected, dFoxO cannot be detected under any experimental condition as shown in figure 35. 
In addition, the MMP1 signal was not stronger in the hypoxia treated animals compared with 
normoxic controls.  
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Figure 35: Activation of Drosophila mmp1 is dFoxO-dependent.  
The generated strain carrying the tracheal driver lines with a defective dFoxO allele (pkk4-gal4:: foxo21) were 
crossed with overexpression lines, driving expression of PGRP-LC in dfoxo24 background (UAS-PGRP-LC::foxo24). 
Larvae were treated with hypoxia (A’-D’. 5% O2) or held under normoxia (A-D, 21% O2). Staining with anti dFoxO 
(green, A, A’), DAPI (blue, B, B’), anti MMP1 (red, C, C’) and the merge of A-C (D) and A’-C’ (D’). 
 
3.18 Transcriptome analysis of Drosophila mmp1 ectopic overexpression 
To define if immune related genes were regulated in case of mmp1 ectopic overexpression, Venn-
diagram tests were performed including the set of known immune genes. Twenty genes were 
identified as being common between immune related genes and genes upregulated following 
ectopic mmp1 overexpression. In addition, three genes are common between the respective 
groups of downregulated genes with immune related genes (figure 36). 
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Figure 36: Comparison of regulated gene sets using Venn diagram analyses.  
Relevant immune response genes (367 genes) were compared with regulated genes during hypoxia, both in wild type 
or mmp1 ectopically activated strains. The comparison show 11 and 20 genes were identical between the upregu-
lated genes in wild type, mmp1 activated and relevant immune genes (A) While, 11 and  3 genes were the association 
between the downregulated genes in the wild type, mmp1 activated and relevant immune genes (B). Seven genes and 
15 were the counterpart between the downregulated genes from wild type and upregulated genes of mmp1 activated 
(C) and vice versa (D). 
Table 2: List of immune relevant genes regulated upon hypoxia in wild-type and mmp1 ectopi-
cally activated strains. 
Gene ID NAME SYMBOL 
Commonly regulated genes between ectopically activated mmp1 and wild-type experienc-
ing hypoxia 
CG10001 Allatostatin Receptor 2 AR-2 
CG12225 Spt6 Spt6 
CG12820 Diacyl glycerol kinase Dgk 
CG13225 Odorant receptor 47a Or47a 
CG18107 - CG18107 
CG2010 - CG2010 
CG31872 - CG31872 
CG32118 - CG32118 
CG4181 Glutathione S transferase D2 GstD2 
CG4533 lethal (2) essential for life l(2)efl 
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CG6084 - CG6084 
CG8253 tungus tun 
Immune relevant genes upregulated in wild-type animals experiencing hypoxia 
CG10697 Dopa decarboxylase Ddc 
CG11159 - CG11159 
CG18108 Immune induced molecule 1 IM1 
CG31764 virus-induced RNA 1 vir-1 
CG4261 Helicase 89B Hel89B 
CG4432 Peptidoglycan recognition protein LC PGRP-LC 
CG4437 Peptidoglycan recognition protein LF PGRP-LF 
CG7228 peste pes 
CG7496 PGRP-SD PGRP-SD 
CG7798 - CG7798 
CG8502 Cuticular protein 49Ac Cpr49Ac 
Immune relevant  genes upregulated in ectopically expressed mmp1 
CG10910 - CG10910 
CG13323 - CG13323 
CG13324 - CG13324 
CG13422 - CG13422 
CG1361 Andropin Anp 
CG15829 - CG15829 
CG16978 - CG16978 
CG18106 Immune induced molecule 2 IM2 
CG18279 Immune induced molecule 10 IM10 
CG5008 Gram-negative bacteria binding protein 3 GNBP3 
CG5097 Metallothionein C MtnC 
CG5778 - CG5778 
CG6467 Jonah 65Aiv Jon65Aiv 
CG6687 Serpin 88Eb Spn88Eb 
CG8293 Inhibitor of apoptosis 2 Iap2 
CG9080 Listericin Listericin 
CG9111 Lysozyme C LysC 
CG9116 Lysozyme P LysP 
CG9120 Lysozyme X LysX 
CG9976 Galactose-specific C-type lectin Lectin-galC1 
Commonly regulated genes in ectopically expressed mmp1 (down) and wild-type animals 
experiencing hypoxia (up) 
CG10017 - CG34340 
CG10563 lethal (2) 37Cd l(2)37Cd 
CG11329 - CG11329 
CG1218 - CG1218 
CG13425 Bancal bl 
CG14958 - CG14958 
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CG15345 - CG15345 
CG17386 - CG17386 
CG18783 Kruppel homolog 1 Kr-h1 
CG31519 Odorant receptor 82a Or82a 
CG4005 Yorkie yki 
CG5893 Dichaete D 
CG8580 Akirin akirin 
CG9209 vacuolar peduncle vap 
CG9815 - CG9815 
Commonly regulated genes in ectopically expressed mmp1 (up) and wild-type animals 
experiencing hypoxia (down) 
CG1079 Fire exit Fie 
CG11999 - CG11999 
CG1262 Accessory gland peptide 62F Acp62F 
CG14322 - CG14322 
CG15829 - CG15829 
CG4221 - CG4221 
CG5279 Rhodopsin 5 Rh5 
Commonly downregulated genes between ectopically expressed mmp1 and wild-type 
animals experiencing hypoxia 
CG12118 - CG12118 
CG14512 - CG14512 
CG1801 - CG1801 
CG31852 Two A-associated protein of 42kDa Tap42 
CG3739 - CG3739 
CG5451 - CG5451 
CG7861 tubulin-specific chaperone E tbce 
CG8007 - CG42796 
Immune relevant  genes that are downregulated in wild-type animals experiencing hypoxia 
CG1358 - CG1358 
CG13641 - CG13641 
CG13795 - CG13795 
CG14841 - CG14841 
CG15829 - CG15829 
CG16713 - CG16713 
CG31509 Turandot A TotA 
CG5909 - CG5909 
CG7417 TAK1-associated binding protein 2 Tab2 
CG9434 Frost Fst 
CG9441 Punch Pu 
Immune relevant  genes downregulated in animals ectopically expressing mmp1 
CG15293 - CG15293 
CG18467 - CG18467 
CG3705 astray aay 
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The comparison of the hierarchical clustering resulting from wild type strains microarray to those 
arrays from the mmp1 ectopic overexpression showed the highest differential gene expression 
over high range of regulated gene sets as figured in 37. 
 
 
 
Figure 37: Hierarchical clustering of wildtype and ectopic activated mmp1. 
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4. Discussion 
In multicellular animals, coordination between the metabolic processes and those systems, which 
supply oxygen, requires a full management to maintain oxygen homeostasis. In mammals, for 
example, local hypoxia is one of the major positive regulators of angiogenesis [133] acting via 
the hypoxia inducible factor (HIF) inducing expression of e.g. the vascular endothelial growth 
factor (VEGF), finally inducing ramification and sprouting of new projections [134, 135]. 
Hypoxia defines a situation of low oxygen tension that is lower than required to maintain a 
homeostatic balance between oxygen tissue supply and consumption. Usually, it occurs when the 
available oxygen concentration in a certain tissue is 5% or lower even lower. Hypoxia can be 
experienced during normal physiology (e.g. during embryogenesis or organ development) or in 
some pathological conditions such as myocardial infarction, sickle cell anaemia, and sleep apnea. 
[136, 137]. In addition, it comes along with various types of inflammation and is highly impor-
tant for chronic lung diseases such as asthma and chronic obstructive pulmonary disease (COPD) 
[138]. Hypoxia can come in different flavours; it can be tissue specific or generalized, intermit-
tent or constant. Otherwise, severe hypoxia can lead to cell death or injury, which may end up in 
severe organ damage or even in death of the organism [136]. 
Since these different hypoxic conditions are inextricably associated with a great variety of 
diseases, a better understanding of the cellular responses towards hypoxia is of great importance. 
Responses to hypoxia are highly context- and tissue-dependent, which is exemplified by the 
different reaction modes to intermittent and constant hypoxia [139]. The long-term effects of 
chronic hypoxia and the contribution of hypoxia to the disease phenotype in pathological states 
such as asthma or COPD are not well understood. Interestingly, we know very little about the 
reaction and role of those cells that are usually the first ones experiencing hypoxia, the airway 
epithelial cells. The airway epithelium, as the central structural component of the airway, is 
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devoted to all aspects associated with gas exchange. In addition, it has been shown that epithelia 
are able to mount an immune response if confronted with pathogens or pathogen associated 
molecular patterns [32, 41]. This type of response mainly depends on the innate immune system 
and should prevent bacterial colonization and/or invasion through the corresponding epithelia. 
Thus, two different modes of responses are operative following recognition of potential patho-
gens, the production and release of cytokines to recruit professional immune cells and the 
production and release of antimicrobial compounds such as antimicrobial peptides or reactive 
oxygen species [140, 141]. In the model used in the current work, the fruit fly Drosophila 
melanogaster, the latter type of response is apparently dominating [32, 41, 65].  
Drosophila is a well-established model for various aspects of biomedical research [142]. Up to 
70% of all human disease genes have counterparts in the fly, thus disclosing the full power of 
Drosophila genetics [143, 144] to elucidate their physiological and pathophysiological role. 
Drosophila shows a well-orchestrated response to hypoxia and has been used as a very informa-
tive model to study the reaction and adaptations towards it [145, 146]. The airway system of the 
fly shares common architectural and structural aspects with both, our lung and our circulatory 
system [41, 88]. Especially the reaction of the airway system of the fly (trachea) to hypoxia has a 
huge number of commonalities with hypoxia-induced angiogenesis observed in the mammalian 
circulatory system [70, 88]. Areas with local oxygen need induce matching growth of airways 
into these regions, a mechanism triggered by the branchless/breathless system (fibroblast growth 
factor/fibroblast growth factor receptor) that depends on HIF-1 [70, 88]. The response of the 
airway epithelium is cell autonomous, meaning that sensing of and reaction to hypoxia reside in 
these epithelial cells [70]. This point to the central role of airway epithelium in response to low 
oxygen tension (hypoxia). Here, I show that hypoxia itself is able to induce an immune response 
in the airway epithelium of the fly without any contact to pathogens or pathogen associated 
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molecular patterns. Interestingly, this reaction doesn’t depend on the major player in the hypoxia 
field, namely HIF-1. Upon hypoxia treatment of third instar larvae, the antifungal peptide gene 
drosomycin was the most prominent upregulated antimicrobial peptide gene. Others, such as 
attacin were also upregulated in complete larvae. In the airways, a similar type of response is 
obvious; indicating that at least some of these transcriptional responses can be attributed to the 
response in the airways. Taking into account that the airways represent only a very small portion 
of the entire animal, other organs in the larvae should also react to hypoxia with an immune 
response. Especially the increased expression of drosomycin is puzzling as it is usually induced in 
a Toll-dependent manner [1, 34, 147-149]. Only in epithelial immunity, this induction is Toll-
independent and is induced via the IMD-pathway [41]. Interestingly, this response depends 
neither of the Toll- nor on the IMD-pathway. Another molecule has recently been identified in 
Drosophila, which has the ability to induce the production of AMPs (e.g., drosomycin) without 
requiring classical immune signaling. It is the Drosophila forkheadbox-O (dFoxO) protein, the 
sole representative of this family in the fly [150]. Under normal conditions, meaning in the 
presence of insulin or insulin-like growth factors the PI3K–Akt/SGK pathway is activated and 
dFoxO is, retained in the cytoplasm. In cases of starvation or hypoxia, when the insulin or 
corresponding growth factor signaling pathways are impaired or absent, FoxO transcription 
factors translocate to the nucleus. I could show that hypoxia is able to recapitulate this signaling, 
as it led to translocation of dFoxO into the nucleus of airway epithelial cells. This translocation 
triggers expression of dFoxO target genes, including some antimicrobial peptide genes, including 
drosomycin. This observation was made either using GFP reporter strains or by measuring the 
corresponding mRNA. This expression was not accompanied by translocation of either of the 
Drosophila NF-κB factors, namely relish, dorsal and dif, further supporting the hypothesis that 
expression of these antimicrobial peptide genes is not triggered by the conventional, NF-κB 
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dependent pathways. As observed for the expression of the antimicrobial peptide drosomycin, the 
reaction of the dFoxO translocation process starts at the most terminal structures of the tracheal 
system and reactions in the major branches are seen only in few animals at later phases of the 
treatment. Even after the hypoxic treatment ended, dFoxO-GFP stayed for a certain time (usually 
more than one hour) in the nucleus before re-entering the cytoplasm. The time before re-entering 
the cytoplasm depended on the period of hypoxia, meaning that the longer the hypoxic treatment, 
the longer stayed dFoxO-GFP in the nucleus after return to normoxic conditions.  
Knockdown of SIMA, which is part of the HIF-machinery, does not impair this response com-
pletely, indicating that the hypoxia-dependent increase in drosomycin expression does also not 
depend on HIF-1 signaling. In contrast, animals defective in dFoxO (foxo21/foxo24 transhetero-
zyotes) show no upregulation of drosomycin expression in response to hypoxia treatment, 
indicating that dFoxO is essential for this response. Together, these data show that dFoxO can 
activate AMP expression independently of the NF-κB-dependent innate immune pathways.  
Different signaling cascades are able to modulate dFoxO signaling including JNK- and insulin- 
pathways [151, 152]. Recently, dFoxO activation has been shown to be responsible for a very 
special type of immune response. Upon starvation, dFoxO dependent activation of antimicrobial 
peptide gene expression can be detected in different organs of the fly. Those genes that are 
regulated upon starvation have dFoxO binding sited in their presumptive promotor regions [150]. 
These data indicate that dFoxO activation is an alternative way to induce an immune response in 
the fly (and presumably not only there). The reason for this unexpected response is yet not 
understood, especially as an immune response is launched without any contact to pathogen or 
activation of classical signal pathways involved in innate immunity. My results imply that this 
reaction is a response to cellular damages or severe cellular stress. dFoxO, as a terminal factor of 
various stress-related signaling pathways, is ideally suited for this purpose. Thus, this may be the 
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fly’s way to react according to the vulnerability hypothesis, meaning that extensive stress leading 
to cell damage or impairment of cell function activate dFoxO, which induces in turn an immune 
response without activation of the classical signal transduction cascades devoted to immunity. 
The link between danger sensing and dFoxO activation followed by expression of antimicrobial 
peptide genes is not understood. Nevertheless, its may be the fly’s equivalent to the danger 
hypothesis originally introduced by Polly Matzinger [153]. Damage of cells and the occurrence 
of danger related signals is according to this theory sufficient to induce a profound immune 
response. Mechanistically, one possibility to link oxygen sensing and insulin signalling has been 
shown in cultured Drosophila S2 cells [154]. Insulin signalling is able to induce Sima-dependent 
gene expression to similar extents as those observed following severe hypoxia. Here, PI3K- and 
TOR-dependent signalling appear to be essential for this interaction [155]. Whereas increased 
insulin signal induces hypoxia related responses via upregulation of Sima in S2 cells, dFoxO 
activation can be induced by decreased insulin signalling in the fly’s airway epithelium. In 
addition, classical HIF-1 dependent signalling is apparently not involved in the hypoxia induced 
drosomycin expression. Alternatively, activation of other signalling systems such as the JNK 
system [156] may represent additional sensors in these cells. Thus, I identified a novel way how 
hypoxia regulates the physiological response of the airway epithelium, which, on the other hand, 
may represent a way how danger signalling operates in innate immunity. 
Upon hypoxia, many structural changes can occur in the airway epithelia of Drosophila. These 
changes comprise, thickening of the epithelium outlining the trachea, via increasing the cell size 
but not its number. These changes match structural changes observed in asthma and/or COPD 
[65]. This reorganization might be the preparatory stage of metaplasia, meaning that the epithelial 
cells undergo a conversion to another, presumably different cell type. This result implies that 
prolonged and severe infections or, even more likely, strong local immune responses induce 
Discussion 
 76
remodeling of the airway epithelium, a situation that resembles the situation observed in chroni-
cally inflamed human airways [65].  
In mammals, comparable structural changes are predominantly seen in the circulatory system. 
Both, the tracheal system of insects and the circulatory system of invertebrates are devoted to 
oxygen supply. Additional branches grow up of preexisting blood vessels in response to hypoxic 
stress. Such phenomena occur only in the superficial tissues of higher animals, because 
the circulatory system is the main transporter for the oxygen overall the body. Hence, this 
process is vital to increase the number of blood vessel, thus ensuring sufficient oxygen supply for 
peripheral tissue. In Drosophila, intensive increase in the number of the terminal branches in 
comparison to control animals was observed following hypoxia treatment in third instar larvae. 
The general structure of the tracheal systems in those animals is almost completed and fully 
functional. Only few cells are qualified for division and formation of branches and buds [70]. At 
normal oxygenation condition (normoxia), the structure of the airways is not changed and de-
pends only on the genetic program realized during tracheal formation. Upon stimulation when 
facing low oxygen tension (hypoxia), HIF-1 is activated. FGF/Branchless in tissues experiencing 
hypoxic conditions binds the receptor breathless on tracheal cells. This complex is formed for 
several times, turned on and off in different locations depending on the oxygen tension, and 
finally inducing the sprouting of new projections in a way comparable to angiogenesis in mam-
malians [70, 105]. 
These processes, the production of new branches and the growths of terminal branches require 
additional mechanisms that enable them. Regarding certain of these aspects, this growth shares 
aspect also required for developmental processes such as molting. During embryonic morphoge-
nesis, the epidermis and tubes of the internal respiratory organ are covered with a chitinous 
sheath. This cuticle barrier determines the ability of the organism to grow. During normal molt-
Discussion 
 77
ing, the attached tracheal cuticular lining is forced externally through the spiracles, openings that 
link the tracheal tubes with the outer ambience as the larvae slithers out the earlier cuticle a new 
cuticle produced before shedding the elder one [157, 158]. The growth of airways occurs by 
increasing cell size and ploidity without increasing cell number. As tracheal elongation occurs in 
the presence of a cuticle, it seems to require cuticle remodeling. Previous reports 
have been shown that a Drosophila matrix metalloproteinase, MMP-1, is required for normal 
tracheal growth. In the mutant MMP-1 strains, the trachea become stretched and broken as the 
larva grows [159]. Other studies have reported that the MMP activity can be regulated at diverse 
ranks: proteolytic activation of the latent zymogen, interactions with endogenous inhibitors, and 
differential localization. In cultured cell lines another way to regulate of MMPs appears to be 
operational, namely direct regulation of secretion [160-162]. 
Numerous studies have studied the role of metalloproteinases in development and immunity [163, 
164]. In the current study, I provide evidence that MMP-1 provide an auxiliary mechanism in 
boosting an appropriate innate immune defense against a bacterial infection. This finding is in 
agreement with recent observations in Tribolium MMP-1 [165]. Beetles defective in the corres-
ponding MMP-1 were more susceptible to infection with enteropathogenic fungi [163]. In 
Drosophila, I found that additional MMP-1 can be found in response to mild stressing events 
such as hypoxia (incubation at 5% O2). The underlying mechanism of MMP-1 activation, wheth-
er upon infection or following stress is still unknown. In this study, I dissected the pathways 
leading to activation of the MMP-1 production. 
In a previous study, we reported an upregulation of AMP genes upon infection with the insect 
pathogen Erwinia carotovora [5]. Here, I give evidence that the expression of AMP genes can be 
regulated upon other environmental challenges such as hypoxia. This regulation was concomitant 
with higher levels on mmp1 mRNA expression. On the other hand, overexpression of mmp1 leads 
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to higher levels of AMP expression. Thus, we have a positive feedback loop that prolongs 
inflammatory processes in the airways. Consequently, induction of mmp1 expression by stressors 
or infection may contribute substantially to the negative effects, e.g. the structural changes that 
are associated with these situations. The question which mechanism can induce upregulation of 
mmp1 is still unresolved.  mmp1 upregulation can either be driven directly via induction of 
dFoxO or indirectly by activation of e.g. the IMD-Relish pathway. In the latter case, the activa-
tion of relish should induce JNK/TAK1 and finally orientates dephosphorylation and nuclear 
translocation of dFoxO via this pathway. 
 To tackle this question experimentally, I used epistatic analyses to unravel the connection 
between both pathways. Activation of the IMD-pathway way sufficient for induction of mmp1 
expression, but repeating this experiment in a dFoxO deficient background revealed that dFoxO 
is required for this response. My data indicate that IMD can activate mmp1 expression presuma-
bly via the JNK pathway, while JNK can be stimulated by other ligands and activate its 
downstream target dFoxO, which finally bifurcates into two different functions: induction of 
mmp1 expression and induction of AMP gene production. Data emerged from this study reported 
that neither dFoxO knocked out, nor BSK-dominant negative animals were able induce MMP1 
protein in the Drosophila trachea upon hypoxia. Collectively, these two observations consum-
mate that dFoxO is a substantial factor in regulation of mmp1 expression, additionally dFoxO in 
case of mild environmental stress functions downstream of JNK. Thus, induction of mmp1 
upregulation is directed by a synergy between JNK, dFoxO and the IMD pathway. The study 
presented here thus illustrates an innovative signaling pathway for mutualistic action of the IMD-
, JNK- and dFoxO-dependent signaling pathways in the regulation of mmp1. 
The primary role of MMP-1 in this context is to enable growth of cells and building of new 
branches. MMP-1, as a metalloproteinase is able to degrade extracellular matrix molecules, thus 
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providing space for growth. Activation of an immune response may be an unwanted by-product 
of this activity. Proteases are able to activate the immune system non-specifically via cleavage of 
pattern recognition receptors. In Drosophila, this has already been reported [166]. A potential 
target for this is the central pattern recognition receptor of the IMD-pathway, PGRP-LC. Its 
cleavage is sufficient for triggering the IMD-pathway and therewith an immune response. The 
activated IMD pathway (via cleavage of PGRP-LC) activates TAK1 (presumably), which then 
stimulates IKK-dependent cleavage and activation of Relish, and the JNK pathway induced 
through TAK1. The JNK usually activates dFoxO during stages of increased stress. dFoxO 
activation provokes transcription of the mmp1 and AMP genes, meanwhile JNK negatively 
regulates the transcription of relish. Thus, activation of dFoxO by stress is part of a negative 
feedback loop to reduce the levels of ROS in the cell environment.  
Microarray analysis of the airway epithelium following ectopic mmp1 expression showed upregu-
lation of different types of genes; very interesting are the lysozymes, where lysozymes C, P and 
X are upregulated. Another molecule with relevance for the immune response is the listericin 
gene (CG9080), which is usually induced in response to L. monocytogenes infection. The listeri-
cin gene encodes a novel AMP-like protein whose induction is cooperatively regulated by PGRP-
LE and the JAK-STAT pathway [167]. 
Another relevant molecule is metallothionein C (CG5097), which is evolutionarily conserved 
from mammals to insects. In Drosophila, expression of metallothionein C is metal-responsive 
transcription factor-1 (MTF-1) dependent. MTF-1 is a transcription factor that possesses DNA 
binding zinc fingers, which change conformation in response to fluctuations in cellular zinc 
concentrations [168]. Upon increase of metal ion levels in the cytoplasm, MTF-1 stimulates the 
transcription of metallothionein genes. Metallothioneins are tiny, cysteine-rich proteins that bind 
zinc under specific physiological conditions; they represent stress inducible genes with a diverse 
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array of functions. Metallothionein genes have also been shown to be transcribed in response to 
hypoxia in a MTF-1-dependent manner [169]. 
In conclusion, it can be said that the fly’s airway system represents a very valuable model to 
study the general aspects of airway systems as the major architectural features of airway epithelia 
appear to be conserved throughout the animal kingdom. Usually, hypoxia induces a complex set 
of responses; most of them are believed to depend on HIF-1 like factors. In Drosophila, the major 
organ, where HIF-1 dependent gene expression in response to hypoxia could be observed is the 
airway epithelium itself [155, 170]. My observation that a potent immune response can be 
launched following hypoxia was unsuspected; especially that it apparently doesn’t depend on 
HIF-1. The involvement of dFoxO in this response was also unexpected and may link locally 
action damage sensing with the induction of an immune response. In addition, the importance of 
dFoxO for the general response to hypoxia was further underpinned by the almost complete lack 
of common transcript signatures following hypoxia in wild-types and dfoxo deficient animals. 
This indicates that dFoxO is not only required to transduce the hypoxia-induced immune re-
sponse but also a great number of different transcriptional responses. Presumably, this dFoxO 
dependent part of the reaction towards hypoxia may be the one that occurs in response to a more 
generalized impairment of cell homeostasis. This hypothesis is underpinned by previous work 
showing that dFoxO is activated during stressful situations in the fly’s airway epithelium, where 
it is essential for cell survival [65]. This type of reaction is physiologically very meaningful as 
especially those regions of the airways (and only those) that experience damages should launch 
an appropriate transcriptional response. In addition, dFoxO appears to be also required to induce 
structural changes directly at the level of the airway epithelial cells including induced thickening 
as well as comparable structural adaptations.  
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On the other hand, the current data indicate that transcriptional regulation of mmp1 is a crucial 
component to the hypoxia-induced immunity in flies. In this case, the JNK-responsive transcrip-
tion factor dFoxO is also required for this response. Although activation of the IMD-pathway is 
sufficient for this response, it requires active dFoxO mediated signaling. MMP-1 is required to 
enable structural changes, but this increased induction is presumably paid by an unspecific 
activation of the innate immune response, mediated via cleavage of pattern recognition receptors. 
My data suggested that MMP-1 activation is part of a vicious cycle that enhances and prolongs 
inflammatory responses in the airway epithelium thus is may by concluded that comparable 
reactions are also relevant for inflammatory diseases of the lung including asthma und COPD.  
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5. Summary 
The tracheal system of insects is a purely epithelial tissue that is primarily devoted to gas ex-
change. All airway epithelial cells of the fruit fly Drosophila melanogaster are immune-
competent, meaning that they are able to mount an immune response if confronted with patho-
gens such as bacteria or fungi. Strong and prolonged activation of this epithelial immune 
response is able to elicit different responses including inflammation-like states and structural 
changes that are reminiscent to those observed in chronic inflammatory diseases of the human 
lung such as asthma or COPD (Chronic Obstructive Pulmonary Disease). The simplicity of the 
fly’s airway system makes it to a credible candidate to examine the mechanisms underlying 
these inflammatory diseases.  
Patient suffering from Asthma bronchiale or COPD often experience hypoxia and/or hypercap-
nia. The current study demonstrates that hypoxia can mount an immune response in the airway 
epithelium of the fruit fly, as shown by the induced expression of antimicrobial peptide genes.  
This response is triggered without any contact to pathogens or pathogen associated molecular 
patterns (PAMPs). Instead, this hypoxia-induced immune response depends on the transcription 
factor dFoxO. Translocation of dFoxO into the nuclei of airway epithelial cells precedes the 
expression of antimicrobial peptides under control of this transcription factor. Apparently, 
dFoxO mediates a danger-like response of the airway epithelium to this stressor. 
In addition, I could show using microarray analyses, that dFoxO is not only necessary for the 
hypoxia induced immune activation, but also for a great variety of other hypoxia-induced tran-
scriptomic responses. Comparing the transcriptomes between wild-type airway epithelia and 
those of animals lacking functional dFoxO revealed only a marginal overlap in the cohorts of 
genes regulated following hypoxia. Taken together, I have shown that dFoxO plays a much 
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larger role for hypoxia-induced gene regulation than it has previously been thought. In addition, 
I identified another dFoxO dependent process that is related to hypoxia-induced responses. 
Following hypoxia, the airways show structural changes including building of new terminal 
branches. To enable this, the matrix metalloproteinase MMP-1 is required to degrade the extra-
cellular matrix around these structures. Expression of mmp1 is induced following infection, but 
also following other stressors such as hypoxia. On the other hand, overexpression of mmp1 in 
airway epithelia induces an immune response. Thus, MMP-1 apparently is part of a positive 
feedback loop leading to a prolonged and more severe immune response in the airway epithe-
lium following an infection. Both, ectopic activation of the innate immune pathway IMD or of 
dFoxO are sufficient to induce mmp1 expression. Epistatic analyses revealed that both res-
ponses critically depend on the presence of dFoxO, which in turn appears to be activated via the 
JNK-pathway. 
The current study reveals that hypoxia induces a great number of unexpected responses in the 
airway epithelium that are mainly transduced via activation of dFoxO. These results are medi-
cally relevant because hypoxia is frequently experienced in different inflammatory diseases of 
the airways (e.g. Asthma and COPD). Apparently, dFoxO is, in addition to HIFs, a novel 
key molecule in the oxygen homeostasis, thus opening a new area for research in this field. 
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6.  Zusammenfassung 
Das tracheale System der Insekten ist ein rein epitheliales Gewebe, das primär dem Gasaustausch 
dient. Alle Atemwegsepithelzellen der Fruchtfliege sind immunkompetent, was bedeutet, dass sie 
nach Pathogenkontakt (z.B. mit Bakterien oder Pilzen), in der Lage sind, eine Immunantwort zu 
zeigen. Es hat sich gezeigt, dass eine sehr starke und langanhaltende Aktivierung des 
Immunsystems dazu führen kann, dass Entzündungs-ähnliche Zustände entstehen. Zusätzlich 
werden auch strukturelle Änderungen induziert, die denen entsprechen, die bei chronisch 
entzündlichen Erkrankungen der Lunge (z.B. Asthma oder COPD – Chronic Obstructive 
Pulmonary Disease) zu beobachten sind. Die strukturelle Einfachheit des Fliegensystems lässt es 
als ideales Modell für die Analyse der diesen Erkrankungen zugrunde liegenden Mechanismen 
erscheinen.  
Patienten, die an Asthma bronchiale oder COPD leiden, erfahren oftmals hypoxische oder 
hyperkapnische Bedingungen. In der vorgelegten Arbeit konnte ich zeigen, dass Hypoxie in der 
Lage ist, eine Immunantwort des Atemwegsepithels zu induzieren. Diese Antwort wird ohne 
jeglichen Kontakt zu Pathogen oder Pathogen Assoziierten Molekularen Mustern (PAMPs) 
hervorgerufen. Diese induzierte Antwort beruht auf der Aktivität des Transkriptionsfaktors 
dFoxO. Hypoxie induziert dessen Translokation in den Kern, ein Prozess, der einer Expression 
antimikrobieller Peptidgene induziert. Offensichtlich vermittelt dFoxO eine sog. Danger-Antwort 
im Atemwegsepithel.   
Außerdem konnte ich mit Hilfe von Microarray Analysen zeigen, dass dFoxO nicht nur für die 
Hypoxie-induzierte Immunantwort, sondern auch für eine Reihe anderer Antworten erforderlich 
ist. Ein Vergleich der Hypoxie-induzierten Genexpressionsmuster von Tracheen isoliert aus 
Wildtyp Larven mit den aus dfoxo-defizienten Larven ergab eine überraschend geringe 
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Übereinstimmung. Zusammenfassend kann gesagt werden, dass ich gezeigt habe, dass dFoxO 
eine sehr viel größere Rolle im Rahme der Hypoxie-vermittelten Antworten spielt als vorher 
angenommen wurde. Außerdem konnte ich einen weiteren dFoxO-abhängigen Prozess 
identifizieren, der direkte Bedeutung für Hypoxie-vermittelte Antworten hat. Hypoxie induziert 
in den Atemwegen strukturelle Änderungen, zu denen die Neubildung von terminalen 
Tracheenästen gehört. Um das zu ermöglichen, ist die Matrix-Metalloprotease MMP-1 
erforderlich, die extrazelluläre Matrix Bestandteile verdaut. Die Expression der mmp1 wird durch 
Infektion, aber auch durch Stressoren wie Hypoxie induziert. Andererseits induziert die 
ektopische Überexpression dieses Moleküls eine Immunantwort in den Tracheen. Demzufolge 
scheint MMP1 Teil einer positiven Rückkopplungsschleife zu sein, die dazu führt, dass 
Antworten auf Infektionen sehr viel stärker und länger in den Atemwegen persistieren. Epistasis 
Analysen konnten zeigen, dass die Aktivierung der mmp1-Expression von dfoxo abhängt und 
wahrscheinlich über den JNK-Signalweg vermittelt wird.  
Die vorgelegte Arbeit zeigt, dass eine Vielzahl unerwarteter Antworten durch Hypoxie in den 
Atemwegen induziert wird und diese vornehmlich vom Transkriptionsfaktor dFoxO abhängen. 
Die Relevanz dieser Ergebnisse ist darin zu sehen, dass Hypoxie oft während entzündlicher 
Erkrankungen der Atemwege (Asthma oder COPD) erfahren wird und einen noch unbekannten 
Anteil an der Pathogenes dieser Erkrankungen einnimmt. Offensichtlich ist dFoxO, zusätzlich zu 
HIF-Faktoren von zentraler Bedeutung für die Hypoxie-Antwort des Atemwegsepithels. 
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8. Appendix 
Table 3: List of upregulated genes upon hypoxia in the wild type strain w1118 
Gene ID Ratio of medians Name 
CG33309 16,486 - 
CG5193 16,486 Transcription factor IIB 
CG14869 16,208 CG14869 
CG5006 16,208 Odorant receptor 33c 
CG12836 16,202 CG12836 
CG17907 16,202 Acetylcholine esterase 
CG1869 16,202 CG1869 
CG31415 9,210 CG31415 
CG7457 8,119 CG7457 
CG3971 7,136 Baldspot 
CG4432 5,963 Peptidoglycan recognition protein LC 
CG8548 5,759 - 
CG9847 5,335 Fkbp13 
CG3213 4,759 CG3213 
CG30259 4,734 CG30259 
CG32677 4,707 CG32677 
CG7440 4,505 Twiggy 
CG32720 4,499 CG32720 
CG31519 4,456 Odorant receptor 82a 
CG7082 4,258 CG7082 
CG17962 4,250 Z600 
CG11761 4,221 Translin 
CG18258 3,926 CG18258 
CG32036 3,783 CG32036 
CG32372 3,727 CG32372 
CG13388 3,701 A kinase anchor protein 200 
CG4261 3,613 Helicase 89B 
CG9168 3,613 CG9168 
CG16944 3,592 stress-sensitive B 
CG2125 3,470 cubitus interruptus 
CG18783 3,461 Kruppel homolog 1 
CG31005 3,450 CG31005 
CG2297 3,433 Obp44a 
CG6052 3,433 CG6052 
CG14323 3,408 CG14323 
CG18107 3,370 CG18107 
CG7496 3,316 PGRP-SD 
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CG8253 3,264 Tungus 
CG8918 3,236 CG8918 
CG3528 3,216 CG3528 
CG8629 3,208 CG8629 
CG12269 3,198 CG12269 
CG9784 3,177 CG9784 
CG116411 3,096 - 
CG3588 3,085 CG3588 
CG31932 3,073 Gustatory receptor 22f 
CG12317 3,041 JhI-21 
CG326873 3,025 - 
CG14303 3,019 CG14303 
CG10563 2,997 CG10563 
CG1832 2,986 CG1832 
CG15207 2,977 CG15207 
CG5705 2,929 CG5705 
CG1674 2,927 CG1674 
CG15663 2,914 - 
CG10732 2,912 CG10732 
CG14715 2,912 CG14715 
CG6391 2,906 Aps 
CG10017 2,890 CG10017 
CG8453 2,878 Cyp6g1 
CG7923 2,836 Fad2 
CG1728 2,824 Tim8 
CG39784 2,802 - 
CG32315 2,773 discs lost 
CG17370 2,762 CG17370 
CG11550 2,736 CG11550 
CG7928 2,725 - 
CG13252 2,721 CG13252 
CG8483 2,719 - 
CG31176 2,714 CG31176 
CG4533 2,707 lethal (2) essential for life 
CG7761 2,696 Parcas 
CG1331 2,683 Ccp84Af 
CG15227 2,674 CG15227 
CG3078 2,667 CG3078 
CG12140 2,666 CG12140 
CG18212 2,650 CG18212 
CG9509 2,631 CG9509 
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CG5893 2,628 Dichaete 
CG2682 2,592 d4 
CG15623 2,590 CG15623 
CG11211 2,570 CG11211 
CG31297 2,551 CG31297 
CG6116 2,551 CG6116 
CG5835 2,550 CG5835 
CG7402 2,538 CG7402 
CG9472 2,525 CG9472 
CG30145 2,523 Odorant-binding protein 57e 
CG11280 2,508 Tartan 
CG31764 2,473 virus-induced RNA 1 
CG8536 2,461 - 
CG15533 2,409 CG15533 
CG30464 2,408 CG30464 
CG172287 2,397 - 
CG10799 2,379 CG10799 
CG8640 2,375 CG8640 
CG17840 2,366 CG17840 
CG7122 2,352 RhoGAP16F 
CG17964 2,335 Pangolin 
CG33045 2,335 - 
CG31116 2,319 CG31116 
CG13958 2,299 CG13958 
CG13350 2,292 CG13350 
CG13425 2,291 Bancal 
CG33291 2,291 CG33291 
CG17608 2,285 fu12 
CG8671 2,280 CG8671 
CG7487 2,278 RecQ4 
CG30374 2,273 CG30374 
CG1530 2,255 CG1530 
CG8197 2,248 CG8197 
CG4181 2,243 Glutathione S transferase D2 
CG10353 2,234 CG10353 
CG14087 2,230 CG14087 
CG18039 2,219 KaiRIA 
CG32975 2,219 - 
CG8695 2,203 Larval visceral protein L 
CG7236 2,198 CG7236 
CG7257 2,182 CG7257 
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CG39152 2,178 - 
CG1827 2,177 CG1827 
CG8853 2,177 CG8853 
CG7011 2,168 CG7011 
CG12334 2,165 Autophagy-specific gene 8b 
CG18340 2,160 Ucp4B 
CG9593 2,160 CG9593 
CG8582 2,158 - 
CG33180 2,145 Ranbp16 
CG40192 2,138 - 
CG31916 2,132 - 
CG12896 2,127 CG12896 
CG4005 2,124 CG4005 
CG8580 2,119 - 
CG15442 2,117 - 
CG12162 2,113 CG12162 
CG11106 2,112 CG11106 
CG16735 2,108 CG16735 
CG17242 2,108 CG17242 
CG30289 2,093 CG30289 
CG8151 2,089 Tfb1 
CG32406 2,088 CG32406 
CG9245 2,086 CG9245 
CG15893 2,085 CG15893 
CG7692 2,083 CG7692 
CG33125 2,067 CG33125 
CG4827 2,064 CG4827 
CG4459 2,060 CG4459 
CG14636 2,058 CG14636 
CG17064 2,058 Mars 
CG18108 2,057 Immune induced molecule 1 
CG11512 2,051 Glutathione S transferase D4 
CG31872 2,051 CG31872 
CG33278 2,051 CG33278 
CG9795 2,045 CG9795 
CG1090 2,039 CG1090 
CG31021 2,039 - 
CG5499 2,038 Histone H2A variant 
CG17386 2,037 CG17386 
CG5862 2,037 CG5862 
CG8635 2,035 CG8635 
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CG11579 2,027 Armadillo 
CG15312 2,023 CG15312 
CG32429 2,018 - 
CG11159 2,011 CG11159 
CG171772 2,009 - 
CG4185 2,008 - 
CG15133 2,006 CG15133 
CG9589 2,000 CG9589 
CG17816 1,999 CG17816 
CG7200 1,996 CG7200 
CG6939 1,991 SET domain binding factor 
CG9323 1,991 CG9323 
CG3209 1,988 CG3209 
CG7196 1,986 CG7196 
CG32033 1,984 CG32033 
CG14997 1,983 CG14997 
CG1221 1,969 Miple 
CG17584 1,968 Odorant receptor 49b 
CG30499 1,965 CG30499 
CG1152 1,961 Glucose dehydrogenase 
CG7228 1,959 CG7228 
CG1838 1,958 Myoglianin 
CG4437 1,956 Peptidoglycan recognition protein LF 
CG9815 1,955 CG9815 
CG6708 1,951 Oxysterol binding protein 
CG13897 1,946 CG13897 
CG7262 1,946 CG7262 
CG15437 1,942 modifier of rpr and grim 
CG8478 1,942 CG8478 
CG8444 1,931 CG8444 
CG16826 1,930 - 
CG33255 1,926 - 
CG5124 1,921 Adipose 
CG8909 1,917 CG8909 
CG33105 1,914 CG33105 
CG11190 1,908 CG11190 
CG18302 1,907 CG18302 
CG13766 1,904 CG13766 
CG17104 1,904 CG17104 
CG7098 1,904 Diskette 
CG303440 1,903 - 
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CG3308 1,903 CG3308 
CG12667 1,895 CG12667 
CG32392 1,895 CG32392 
CG31713 1,892 CG31713 
CG3558 1,886 CG3558 
CG33057 1,879 CG33057 
CG17299 1,878 - 
CG15345 1,876 CG15345 
CG32150 1,876 CG32150 
CG6084 1,875 CG6084 
CG6410 1,870 CG6410 
CG8320 1,870 CG8320 
CG11044 1,862 - 
CG30377 1,859 CG30377 
CG8337 1,859 - 
CG18788 1,855 CG18788 
CG1669 1,851 - 
CG17784 1,850 CG17784 
CG11836 1,848 CG11836 
CG15387 1,846 CG15387 
CG4450 1,845 CG4450 
CG18641 1,842 CG18641 
CG1216 1,841 Mrityu 
CG9735 1,830 Tryptophanyl-tRNA synthetase 
CG13834 1,826 CG13834 
CG14080 1,824 Mitogen-activated protein kinase phosphatase 3 
CG13225 1,823 Odorant receptor 47a 
CG8830 1,822 CG8830 
CG4033 1,819 RNA polymerase I 135kD subunit 
CG5719 1,819 - 
CG5813 1,817 Chiffon 
CG14684 1,814 CG14684 
CG10747 1,812 CG10747 
CG11811 1,809 CG11811 
CG10080 1,805 CG10080 
CG8401 1,803 CG8401 
CG8823 1,803 Lip3 
CG31955 1,799 CG31955 
CG1213 1,797 CG1213 
CG17261 1,797 CG17261 
CG31673 1,791 CG31673 
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CG6623 1,790 CG6623 
CG10001 1,788 Allatostatin Receptor 2 
CG12338 1,788 CG12338 
CG13120 1,785 CG13120 
CG31857 1,780 CG31857 
CG8237 1,775 CG8237 
CG32364 1,774 CG32364 
CG10627 1,773 CG10627 
CG17387 1,770 CG17387 
CG17680 1,767 CG17680 
CG12587 1,766 CG12587 
CG11329 1,762 CG11329 
CG14820 1,762 CG14820 
CG9195 1,762 - 
CG18186 1,759 CG18186 
CG3803 1,759 CG3803 
CG7115 1,759 CG7115 
CG7705 1,759 CG7705 
CG15504 1,757 doublesex-Mab related 99B 
CG2457 1,757 inaF 
CG8181 1,756 CG8181 
CG10139 1,750 CG10139 
CG10339 1,750 CG10339 
CG9046 1,748 Vitelline membrane 26Ab 
CG31037 1,747 - 
CG1480 1,744 Bottleneck 
CG12820 1,736 CG12820 
CG1690 1,736 CG1690 
CG18193 1,735 CG18193 
CG9200 1,733 CG9200 
CG10233 1,728 CG10233 
CG12732 1,726 CG12732 
CG31353 1,726 CG31353 
CG14235 1,725 CG14235 
CG17743 1,725 Pleiohomeotic 
CG14187 1,724 CG14187 
CG15023 1,723 CG15023 
CG8789 1,721 CG8789 
CG8890 1,720 GDP-mannose 4 
CG30273 1,716 CG30273 
CG15514 1,715 CG15514 
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CG17086 1,715 CG17086 
CG6333 1,714 CG6333 
CG10435 1,713 CG10435 
CG31501 1,712 nuclear export factor 4 
CG31058 1,707 CG31058 
CG10246 1,706 Cytochrome P450-6a9 
CG40169 1,706 - 
CG4960 1,705 CG4960 
CG6126 1,705 CG6126 
CG6696 1,703 CG6696 
CG15671 1,702 crossveinless 2 
CG1512 1,699 cul-2 
CG66050 1,698 - 
CG8481 1,696 CG8481 
CG8922 1,692 - 
CG18324 1,690 CG18324 
CG14842 1,682 CG14842 
CG18572 1,682 Rudimentary 
CG15786 1,681 CG15786 
CG14958 1,679 CG14958 
CG6747 1,679 Inwardly rectifying potassium channel 
CG3939 1,676 CG3939 
CG9731 1,671 CG9731 
CG12019 1,670 Cdc37 
CG15438 1,670 CG15438 
CG4729 1,668 CG4729 
CG10396 1,667 CG10396 
CG7179 1,665 CG7179 
CG31315 1,662 CG31315 
CG31745 1,658 CG31745 
CG17648 1,657 CG17648 
CG9776 1,657 CG9776 
CG5660 1,654 CG5660 
CG8874 1,654 Fps oncogene analog 
CG31311 1,653 - 
CG12225 1,652 Spt6 
CG31709 1,651 CG31709 
CG15314 1,649 CG15314 
CG1736 1,649 - 
CG4168 1,648 CG4168 
CG1307 1,646 CG1307 
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CG8403 1,644 SP2353 
CG17268 1,643 - 
CG17610 1,643 Gurken 
CG10638 1,642 CG10638 
CG40195 1,642 - 
CG10369 1,641 Inwardly rectifying potassium channel 3 
CG9366 1,638 rho-like 
CG12045 1,637 CG12045 
CG6154 1,637 CG6154 
CG8340 1,631 - 
CG11656 1,629 CG11656 
CG1131 1,627 - 
CG2530 1,626 Corto 
CG14499 1,625 - 
CG18132 1,625 CG18132 
CG15218 1,624 Cyclin K 
CG9280 1,624 Glutactin 
CG12600 1,621 - 
CG15329 1,621 hold'em 
CG2292 1,617 CG2292 
CG31098 1,616 CG31098 
CG31371 1,615 CG31371 
CG12236 1,614 CG12236 
CG8219 1,613 CG8219 
CG41041 1,608 - 
CG12802 1,606 CG12802 
CG17626 1,606 - 
CG12094 1,603 CG12094 
CG14516 1,599 - 
CG51300 1,598 - 
CG5295 1,597 CG5295 
CG31925 1,596 CG31925 
CG4220 1,595 elbow B 
CG2201 1,593 CG2201 
CG10486 1,592 CG10486 
CG10801 1,592 CG10801 
CG14223 1,592 CG14223 
CG2574 1,592 CG2574 
CG7127 1,592 exo70 
CG3278 1,590 - 
CR31485 1,590 - 
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CG9526 1,586 CG9526 
CG14014 1,585 CG14014 
CG9057 1,581 - 
CG2010 1,580 CG2010 
CG12259 1,579 CG12259 
CG7798 1,579 CG7798 
CG5571 1,578 - 
CG32246 1,576 CG32246 
CG32356 1,575 Ecdysone-inducible gene E1 
CG9209 1,572 vacuolar peduncle 
CG1218 1,571 CG1218 
CG12654 1,571 CG12654 
CG10090 1,569 Tim17a1 
CG14871 1,566 CG14871 
CG6700 1,566 CG6700 
CG11513 1,565 Armitage 
CG4900 1,565 Iron regulatory protein 1A 
CG4212 1,562 Rab-protein 14 
CG2899 1,561 kinase suppressor of ras 
CG32750 1,561 CG32750 
CG32118 1,558 CG32118 
CG14151 1,557 CG14151 
CG18327 1,557 CG18327 
CG31874 1,557 CG31874 
CG5412 1,556 CG5412 
CG10205 1,549 CG10205 
CG31772 1,549 CG31772 
CG8258 1,547 CG8258 
CG6875 1,546 abnormal spindle 
CG18811 1,544 CG18811 
CG3897 1,543 bloated tubules 
CG31050 1,542 CG31050 
CG17489 1,539 - 
CG5400 1,539 Eclosion hormone 
CG8161 1,538 Rlb1 
CG3953 1,537 lethal (3) IX-14 
CG9541 1,536 CG9541 
CG8502 1,535 CG8502 
CG6454 1,534 CG6454 
CG10697 1,533 Dopa decarboxylase 
CG31900 1,532 CG31900 
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CG14503 1,531 CG14503 
CG30033 1,531 CG30033 
CG30424 1,531 CG30424 
CG40113 1,530 - 
CG7404 1,530 estrogen-related receptor 
CG31012 1,529 CG31012 
CG14317 1,528 CG14317 
CG7085 1,525 lethal (2) s5379 
CG18518 1,524 CG18518 
CG11120 1,522 CG11120 
CG12081 1,522 CG12081 
CG32561 1,522 xmas-1 
CG6401 1,518 CG6401 
CG3561 1,517 CG3561 
CG9390 1,516 Acetyl Coenzyme A synthase 
CG6695 1,511 CG6695 
CG31732 1,506 - 
CG12153 1,505 Hira 
CG12855 1,505 CG12855 
CG10711 1,502 CG10711 
Table 4: List of downregulated genes upon hypoxia in the wild type strain w1118 
Gene ID Ratio of medians Name 
CG6653 -6,731 Ugt86De 
CG32830 -6,198 CG32830 
CG12118 -5,460 CG12118 
CG13339 -4,918 CG13339 
CG1801 -4,899 - 
CG2837 -4,602 CG2837 
CG12752 -4,582 NTF2-related export protein 1 
CG31195 -4,561 CG31195 
CG5451 -4,420 CG5451 
CG31852 -4,402 Two A-associated protein of 42kDa 
CG14379 -4,104 CheA87a 
CG6937 -4,062 CG6937 
CG3162 -4,052 CG3162 
CG3539 -4,042 SLY-1 homologous 
CG7847 -3,987 stripe 
CG12072 -3,978 warts 
CG14117 -3,973 CG14117 
CG1129 -3,965 CG1129 
CG10971 -3,863 CG10971 
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CG11278 -3,789 Syntaxin 13 
CG5274 -3,752 CG5274 
CG4771 -3,652 CG4771 
CG13116 -3,646 CG13116 
CG7084 -3,642 CG7084 
CG9682 -3,627 CG9682 
CG17633 -3,617 CG17633 
CG13545 -3,561 CG13545 
CG7502 -3,487 CG7502 
CG9997 -3,339 CG9997 
CG4342 -3,290 CG4342 
CG11048 -3,249 CG11048 
CG9023 -3,248 Drip 
CG6148 -3,230 Putative Achaete Scute Target 1 
CG16716 -3,225 CG16716 
CG1982 -3,218 Sorbitol dehydrogenase 1 
CG14312 -3,173 CG14312 
CG31069 -3,162 spindle D 
CG8532 -3,087 liquid facets 
CG13869 -3,071 CG13869 
CR30298 -3,065 - 
CG31812 -3,060 CG31812 
CG11404 -3,005 CG11404 
CG2224 -2,965 CG2224 
CG30105 -2,952 CG30105 
CG10670 -2,931 XPG-like endonuclease 
CG15128 -2,931 CG15128 
CG127892 -2,929 - 
CG3523 -2,926 CG3523 
CG15657 -2,872 CG15657 
CG1656 -2,869 lectin-46Ca 
CG12661 -2,862 CG12661 
CG10249 -2,859 CG10249 
CG4720 -2,839 Protein kinase at 92B 
CG15279 -2,819 CG15279 
CG10874 -2,817 CG10874 
CG12091 -2,782 CG12091 
CG9503 -2,770 CG9503 
CG9470 -2,739 Metallothionein A 
CG9434 -2,734 Frost 
CG4584 -2,733 Deoxyuridine triphosphatase 
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CG1637 -2,708 CG1637 
CG30016 -2,685 CG30016 
CG14167 -2,660 insulin-like peptide 3 
CG3060 -2,660 morula 
CG11555 -2,645 CG11555 
CG3265 -2,644 Eb1 
CG31509 -2,638 Turandot A 
CG10171 -2,624 CG10171 
CG13091 -2,611 CG13091 
CG2194 -2,605 Rhythmically expressed gene 3 
CG5803 -2,594 Fasciclin 3 
CG11958 -2,588 Calnexin 99A 
CG15001 -2,583 - 
CG15538 -2,571 Osiris 23 
CG2973 -2,546 CG2973 
CG17369 -2,529 Vacuolar H 
CG6189 -2,505 lethal (1) 1Bi 
CG11614 -2,501 naked cuticle 
CG9030 -2,501 CG9030 
CG10531 -2,480 CG10531 
CG11999 -2,479 CG11999 
CG14841 -2,420 CG14841 
CG14506 -2,397 CG14506 
CG31292 -2,394 CG31292 
CG5185 -2,390 Twin of m4 
CG6975 -2,389 gigas 
CG11398 -2,381 CG11398 
CG11552 -2,377 - 
CG9426 -2,377 CG9426 
CG18660 -2,367 Nckx30C 
CG32676 -2,354 CG32676 
CG33478 -2,322 Odorant receptor 46a 
CG1079 -2,305 CG1079 
CG7077 -2,296 CG7077 
CG10694 -2,283 CG10694 
CG14322 -2,278 CG14322 
CG11693 -2,269 CG11693 
CG7417 -2,265 Tab2 
CG10513 -2,236 CG10513 
CG3739 -2.205 CG3739 
CG3671 -2.186 Malvolio 
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CG7756 -2,168 Heat shock protein cognate 2 
CG10725 -2,162 CG10725 
CG9569 -2,158 - 
CG38110 -2,153 - 
CG32709 -2,142 CG32709 
CG7438 -2,138 Myosin 31DF 
CG7497 -2,137 - 
CG10516 -2,127 CG10516 
CG7595 -2,127 crinkled 
CG11105 -2,117 CG11105 
CG32031 -2,111 Arginine kinase 
CG30038 -2,084 CG30038 
CG3920 -2,076 lethal (2) k16918 
CG7861 -2,066 CG7861 
CG8617 -2,065 CG8617 
CG7899 -2,059 Acid phosphatase 1 
CG15829 -2,053 CG15829 
CG13349 -2,051 CG13349 
CG32114 -2,051 CG32114 
CG7057 -2,043 AP-50 
CG7587 -2,042 CG7587 
CG10324 -2,036 CG10324 
CG32158 -2,035 CG32158 
CG32380 -2,032 - 
CG12496 -2,027 CG12496 
CG14885 -2,021 Guanylyl cyclase at 89Da 
CG5333 -2,013 CG5333 
CG2508 -2,004 cdc23 
CG40484 -2,002 - 
CG64462 -1,998 - 
CG3880 -1,993 CG3880 
CG5909 -1,978 CG5909 
CG7935 -1,973 moleskin 
CG5279 -1,961 Rhodopsin 5 
CG5327 -1,957 - 
CG9018 -1,950 CG9018 
CG16713 -1,945 CG16713 
CG32945 -1,945 CG32945 
CG8008 -1,927 CG8008 
CG16704 -1,918 CG16704 
CG14395 -1,898 CG14395 
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CG81200 -1,893 - 
CG8335 -1,893 CG8335 
CG31821 -1,889 CG31821 
CG30178 -1,884 CG30178 
CG13791 -1,877 CG13791 
CG9921 -1,871 CG9921 
CG3008 -1,865 CG3008 
CG7704 -1,852 TBP-associated factor 5 
CG15141 -1,841 CG15141 
CG12674 -1,840 CG12674 
CG4221 -1,835 CG4221 
CG5929 -1,824 CG5929 
CG10655 -1,807 lethal (2) 37Bb 
CG30432 -1,807 CG30432 
CG4372 -1,806 CG4372 
CG15509 -1,805 - 
CG5310 -1,799 nmdyn-D6 
CG15658 -1,798 CG15658 
CG1358 -1,795 CG1358 
CG16747 -1,766 Ornithine decarboxylase antizyme 
CG31815 -1,757 CG31815 
CG78755 -1,752 - 
CG3183 -1,741 - 
CG3323 -1,740 CG3323 
CG12212 -1,731 pebbled 
CG14492 -1,730 CG14492 
CG5156 -1,727 CG5156 
CG5958 -1,725 CG5958 
CG13548 -1,724 CG13548 
CG4780 -1,717 CG4780 
CG17367 -1,715 Lnk 
CG4271 -1,713 CG4271 
CG16834 -1,708 lectin-33A 
CG3764 -1,703 CG3764 
CG1877 -1,700 lin-19-like 
CG7728 -1,682 CG7728 
CG4918 -1,678 Ribosomal protein LP2 
CG8908 -1,674 CG8908 
CG10536 -1,669 crossbronx 
CG7498 -1,668 CG7498 
CG13840 -1,656 CG13840 
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CG15261 -1,654 CG15261 
CG12825 -1,652 CG12825 
CG17244 -1,651 CG17244 
CG4573 -1,650 CG4573 
CG13321 -1,649 CG13321 
CG2070 -1,648 CG2070 
CG4781 -1,648 CG4781 
CG2685 -1,647 CG2685 
CG32171 -1,638 Limpet 
CG304186 -1,631 - 
CG10105 -1,627 CG10105 
CG1262 -1,627 Accessory gland peptide 62F 
CG15370 -1,619 CG15370 
CG3661 -1,619 Ribosomal protein L23 
CG8884 -1,615 Synapse-associated protein 47kD 
CG9441 -1,609 Punch 
CG6194 -1,605 CG6194 
CG6463 -1,600 - 
CG1737 -1,597 CG1737 
CG4371 -1,586 Glutathione S transferase D7 
CG11686 -1,582 CG11686 
CG31064 -1,578 CG31064 
CG5854 -1,578 CG5854 
CG7059 -1,578 CG7059 
CG3611 -1,575 CG3611 
CG18468 -1,565 CG18468 
CG6817 -1,562 fear-of-intimacy 
CG8007 -1,557 CG8007 
CG18104 -1,553 arginase 
CG32691 -1,548 CG32691 
CG7049 -1,544 - 
CG16974 -1,543 CG16974 
CG13641 -1,540 CG13641 
CG14053 -1,536 CG14053 
CG1273 -1,531 CG1273 
CG32582 -1,526 CG32582 
CG7848 -1,523 CG7848 
CG14512 -1,517 - 
CG13795 -1,515 CG13795 
CG11209 -1,511 pickpocket 6 
CG5656 -1,510 CG5656 
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CG15924 -1,509 CG15924 
CG31104 -1,508 CG31104 
CG10585 -1,502 CG10585 
Table 5: List of upregulated genes upon hypoxia in the dFoxO mutant strain foxo21 
Gene ID Ratio of medians Name 
CG6751 5,750 CG6751 
CG17957 4,070 - 
CG33180 3,446 Ranbp16 
CG11170 3,362 CG11170 
CG6937 3,345 CG6937 
CG12732 3,305 CG12732 
CG32392 3,001 CG32392 
CG10563 2,975 CG10563 
CG4721 2,904 CG4721 
CG17888 2,811 PAR-domain protein 1 
CG33125 2,793 CG33125 
CG32513 2,741 bves 
CG7236 2,638 CG7236 
CG15173 2,613 CG15173 
CG7145 2,608 CG7145 
CG1442 2,597 CG1442 
CG12184 2,591 CG12184 
CG6654 2,541 CG6654 
CG13652 2,486 CG13652 
CG32106 2,350 CG32106 
CG11450 2,287 net 
CG10761 2,229 CG10761 
CG3168 2,213 CG3168 
CG34010 2,206 - 
CG8786 2,201 CG8786 
CG13917 2,184 CG13917 
CG12680 2,173 CG12680 
CG4313 2,161 CG4313 
CG8245 2,115 CG8245 
CG14303 2,112 CG14303 
CG18180 2,110 CG18180 
CG32069 2,105 CG32069 
CG1081 2,104 - 
CG14493 2,096 - 
CG18568 2,079 CG18568 
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CG32488 2,059 CG32488 
CG14334 2,035 beaten path IIa 
CG33304 2,028 rhomboid-5 
CG1776 2,006 CG1776 
CG3715 1,997 SHC-adaptor protein 
CG4756 1,972 CG4756 
CG3955 1,934 CG3955 
CG12667 1,925 CG12667 
CG18031 1,921 CG18031 
CG4694 1,920 hermaphrodite 
CG8818 1,919 CG8818 
CG13567 1,897 CG13567 
CG7227 1,891 CG7227 
CG7200 1,880 CG7200 
CG1394 1,873 CG1394 
CG7228 1,867 CG7228 
CG31103 1,857 CG31103 
CG40413 1,815 - 
CG17258 1,810 CG17258 
CG7097 1,807 CG7097 
CG15010 1,804 archipelago 
CG10014 1,803 CG10014 
CG10240 1,792 Cyp6a22 
CG17387 1,778 CG17387 
CG31741 1,772 CG31741 
CG9928 1,762 CG9928 
CG10747 1,754 CG10747 
CG13162 1,751 CG13162 
CG17648 1,743 CG17648 
CG14687 1,738 CG14687 
CG31397 1,735 CG31397 
CG15710 1,718 CG15710 
CG32445 1,717 CG32445 
CG5278 1,714 CG5278 
CG6744 1,701 CG6744 
CG8005 1,691 CG8005 
CG17443 1,682 - 
CG6232 1,682 CG6232 
CG32504 1,679 CG32504 
CG13459 1,677 - 
CG33255 1,663 - 
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CG17976 1,661 sugar transporter 3 
CG12165 1,657 Inner centromere protein 
CG6386 1,655 ballchen 
CG31723 1,644 CG31723 
CG10855 1,640 CG10855 
CG14309 1,634 CG14309 
CG12820 1,630 CG12820 
CG31179 1,620 CG31179 
CG7229 1,610 CG7229 
CG3743 1,596 MTF-1 
CR32747 1,594 - 
CG7257 1,593 CG7257 
CG3143 1,587 forkhead box 
CG10756 1,583 TBP-associated factor 13 
CG3587 1,581 CG3587 
CG10192 1,576 CG10192 
CG3595 1,573 spaghetti squash 
CG11820 1,572 CG11820 
CG17028 1,564 CG17028 
CG31251 1,562 CG31251 
CG31953 1,553 CG31953 
CG14865 1,543 lethal (3) neo43 
CG3324 1,543 cGMP-dependent protein kinase 21D 
CG32975 1,538 - 
CG2278 1,531 CG2278 
CG6325 1,531 CG6325 
CG11089 1,512 CG11089 
CG9084 1,512 CG9084 
CG14401 1,508 CG14401 
CG6478 1,505 CG6478 
Table 6: List of downregulated genes upon hypoxia in the dFoxO mutant strain foxo21 
Gene ID Ratio of medians Name 
CG12700 -8,341 skpD 
CG10177 -6,717 CG10177 
CG17946 -6,704 Male-specific RNA 84Da 
CG11248 -5,781 CG11248 
CG32043 -5,422 CG32043 
CG4447 -4,921 CG4447 
CG13830 -4,728 CG13830 
CG12923 -4,503 CG12923 
CG32709 -4,441 CG32709 
CG8885 -4,338 CG8885 
CG13875 -4,206 CG13875 
CG1801 -3,960 - 
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CG13170 -3,919 CG13170 
CG8836 -3,904 CG8836 
CG14463 -3,816 CG14463 
CG2233 -3,564 CG2233 
CG14841 -3,527 CG14841 
CG1774 -3,438 CG1774 
CG1402 -3,432 CG1402 
CG11981 -3,422 - 
CG30353 -3,405 CG30353 
CG33454 -3,369 - 
CG31292 -3,302 CG31292 
CG11175 -3,240 CG11175 
CG8580 -3,215 - 
CG32743 -3,205 Smg1 
CG9653 -3,190 brinker 
CG4631 -3,171 CG4631 
CG2956 -3,142 twist 
CG27742 -3,120 - 
CG13807 -3,08 CG13807 
CG15642 -3,082 CG15642 
CG32719 -3,080 CG32719 
CG15742 -3,058 CG15742 
CG4598 -3,033 CG4598 
CG8090 -3,031 CG8090 
CG4208 -2,988 XRCC1 
CG16785 -2,959 frizzled 3 
CR40474 -2,928 - 
CG7931 -2,923 janus B 
CG3267 -2,880 CG3267 
CG11259 -2,864 MICAL-like 
CG6953 -2,853 fat-spondin 
CG32715 -2,827 CG32715 
CG17280 -2,784 CG17280 
CG4103 -2,757 CG4103 
CG11873 -2,731 CG11873 
CG17190 -2,710 CG17190 
CG18026 -2,705 - 
CG9539 -2,696 - 
CG11024 -2,681 - 
CG14290 -2,643 CG14290 
CG4673 -2,631 CG4673 
CG5055 -2,619 bazooka 
CG5554 -2,616 CG5554 
CG32983 -2,605 CG32983 
CG32044 -2,570 CG32044 
CG119880 -2,561 - 
CG12128 -2,543 CG12128 
CG32568 -2,543 CG32568 
CG13064 -2,527 - 
CG11313 -2,523 CG11313 
CG18109 -2,519 CG18109 
CG4207 -2,515 bonsai 
CG14237 -2,506 CG14237 
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CG8977 -2,493 - 
CG13980 -2,491 CG13980 
CG40470 -2,490 - 
CG3611 -2,483 CG3611 
CG4535 -2,456 FK506-binding protein FKBP59 
CG1697 -2,432 rhomboid-4 
CG10513 -2,424 CG10513 
CG14894 -2,423 CG14894 
CG7516 -2,411 CG7516 
CG18648 -2,409 - 
CG7049 -2,406 - 
CG4206 -2,397 Minichromosome maintenance 3 
CG7614 -2,391 Mat1 
CG6545 -2,384 ladybird early 
CG13271 -2,381 Ugt36Bb 
CG4426 -2,378 asteroid 
CG2973 -2,365 CG2973 
CG325915 -2,364 - 
CG15690 -2,362 CG15690 
CG9186 -2,357 CG9186 
CG40127 -2,352 - 
CG31620 -2,342 Gustatory receptor 39b 
CG31738 -2,342 CG31738 
CG6988 -2,332 Protein disulfide isomerase 
CG11906 -2,328 CG11906 
CG14032 -2,324 Cyp4ac1 
CG4140 -2,312 CG4140 
CG7861 -2,311 CG7861 
CG4780 -2,306 CG4780 
CG1851 -2,305 Ady43A 
CG13855 -2,296 CG13855 
CG9079 -2,292 CG9079 
CG2204 -2,291 - 
CG8223 -2,291 CG8223 
CG17525 -2,267 Glutathione S transferase E4 
CG2244 -2,265 MTA1-like 
CG40182 -2,260 - 
CG4699 -2,253 CG4699 
CG4453 -2,252 Nup153 
CG4183 -2,248 Heat shock protein 26 
CG6686 -2,246 CG6686 
CG8585 -2,243 - 
CG3943 -2,223 kraken 
CG4362 -2,216 CG4362 
CG18678 -2,212 CG18678 
CG32613 -2,208 CG32613 
CG9384 -2,178 CG9384 
CG4205 -2,174 Ferredoxin 
CG9590 -2,158 CG9590 
CG39540 -2,136 - 
CG11236 -2,129 CG11236 
CG14047 -2,127 CG14047 
CG7069 -2,127 CG7069 
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CG30027 -2,109 - 
CG11757 -2,100 CG11757 
CG10759 -2,087 Odorant receptor 7a 
CG12993 -2,079 CG12993 
CG15369 -2,072 CG15369 
CG12508 -2,058 CG12508 
CG4110 -2,036 - 
CG6490 -2,032 CG6490 
CG14117 -2,029 CG14117 
CG16971 -2,025 - 
CG13924 -2,022 CG13924 
CG17601 -2,014 CG17601 
CG10171 -2,013 CG10171 
CG14395 -2,010 CG14395 
CG32633 -2,008 CG32633 
CG4590 -2,007 innexin 2 
CG4520 -1,993 CG4520 
CG7476 -1,987 methuselah-like 7 
CG6944 -1,980 Lamin 
CG32955 -1,973 - 
CG2984 -1,972 Protein phosphatase 2C 
CG30430 -1,963 CG30430 
CG12061 -1,959 - 
CG15862 -1,954 cAMP-dependent protein kinase R2 
CG17746 -1,953 CG17746 
CG3108 -1,953 CG3108 
CG11994 -1,952 Adenosine deaminase 
CG33044 -1,949 - 
CG6424 -1,942 CG6424 
CG4271 -1,932 CG4271 
CG30398 -1,931 CG30398 
CG8613 -1,912 CG8613 
CG6406 -1,911 CG6406 
CR32730 -1,911 - 
CG13476 -1,910 CG13476 
CG12656 -1,904 CG12656 
CG32226 -1,896 CG32226 
CG6515 -1,896 Tachykinin-like receptor at 86C 
CG12072 -1,894 warts 
CG17745 -1,887 CG17745 
CG31274 -1,883 - 
CG9023 -1,880 Drip 
CG9841 -1,877 EfSec 
CG7691 -1,871 CG7691 
CG31835 -1,868 CG31835 
CG4677 -1,868 - 
CG5185 -1,858 Twin of m4 
CG7622 -1,857 Ribosomal protein L36 
CG17765 -1,853 CG17765 
CG7676 -1,851 CG7676 
CG9030 -1,850 CG9030 
CG13129 -1,848 CG13129 
CG31605 -1,832 Basigin 
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CG7429 -1,832 CG7429 
CG5308 -1,820 dpr5 
CG17368 -1,818 CG17368 
CG14909 -1,810 CG14909 
CG13393 -1,808 CG13393 
CG9705 -1,800 CG9705 
CG31244 -1,791 CG31244 
CG7046 -1,791 CG7046 
CG2691 -1,781 CG2691 
CG3107 -1,781 CG3107 
CG9019 -1,781 dissatisfaction 
CG17461 -1,778 Kif3C 
CG11333 -1,771 CG11333 
CG31373 -1,771 CG31373 
CG6226 -1,765 FK506-binding protein 1 
CG8861 -1,765 CG8861 
CG5880 -1,762 CG5880 
CG32642 -1,761 CG32642 
CG31876 -1,759 CG31876 
CG18581 -1,755 CG18581 
CG12169 -1,752 CG12169 
CG31472 -1,752 CG31472 
CG1644 -1,750 Cyp6t1 
CG7459 -1,750 Copper transporter 1B 
CG2616 -1,747 CG2616 
CG4672 -1,742 TMS1 
CG17905 -1,738 CG17905 
CG10346 -1,736 Grip71 
CG11209 -1,735 pickpocket 6 
CG3032 -1,724 CG3032 
CG12865 -1,717 CG12865 
CG17816 -1,717 CG17816 
CG31033 -1,717 CG31033 
CG32462 -1,715 CG32462 
CG17698 -1,711 - 
CG18557 -1,710 CG18557 
CG8966 -1,708 CG8966 
CG8884 -1,700 Synapse-associated protein 47kD 
CG4726 -1,692 CG4726 
CG9682 -1,691 CG9682 
CG11601 -1,689 CG11601 
CG8870 -1,689 CG8870 
CG32686 -1,681 CG32686 
CG7028 -1,678 CG7028 
CG16998 -1,677 CG16998 
CG7564 -1,675 CG7564 
CG17009 -1,674 CG17009 
CG7166 -1,674 CG7166 
CG32611 -1,672 CG32611 
CG11686 -1,671 CG11686 
CG4887 -1,669 CG4887 
CG6296 -1,666 CG6296 
CG13681 -1,665 CG13681 
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CG11278 -1,661 Syntaxin 13 
CG6289 -1,661 CG6289 
CG14160 -1,660 CG14160 
CG14367 -1,660 CG14367 
CG1721 -1,654 Phosphoglyceromutase 
CG30438 -1,654 CG30438 
CG8620 -1,653 CG8620 
CG9159 -1,649 Kruppel homolog 2 
CG8874 -1,644 Fps oncogene analog 
CG13062 -1,643 CG13062 
CG30416 -1,638 CG30416 
CG32589 -1,638 - 
CG6463 -1,628 - 
CG14724 -1,626 Cytochrome c oxidase subunit Va 
CG12936 -1,624 CG12936 
CG12427 -1,620 CG12427 
CG30158 -1,619 CG30158 
CG15547 -1,617 CG15547 
CG1994 -1,614 lethal (1) G0020 
CG12740 -1,612 Ribosomal protein L28 
CG6999 -1,605 CG6999 
CG33277 -1,604 CG33277 
CG3926 -1,604 Serine pyruvate aminotransferase 
CG14506 -1,598 CG14506 
CG39784 -1,597 - 
CG4221 -1,593 CG4221 
CG13935 -1,592 CG13935 
CG31141 -1,588 CG31141 
CG18768 -1,584 SP2523 
CG6174 -1,584 Actin-related protein 87C 
CG7267 -1,584 CG7267 
CG8435 -1,575 CG8435 
CG15400 -1,574 CG15400 
CG14834 -1,573 CG14834 
CG18582 -1,573 mushroom bodies tiny 
CG4329 -1,571 CG4329 
CG8072 -1,571 CG8072 
CG7016 -1,569 CG7016 
CG14408 -1,567 CG14408 
CG7467 -1,563 osa 
CG17906 -1,561 CG17906 
CG13059 -1,558 CG13059 
CG18085 -1,556 sevenless 
CG7054 -1,556 CG7054 
CG14291 -1,554 CG14291 
CG18271 -1,554 CG18271 
CG41106 -1,554 - 
CG33350 -1,552 CheB42c 
CG5093 -1,549 Dorsocross3 
CG14394 -1,545 CG14394 
CG18476 -1,543 CG18476 
CG32496 -1,541 CG32496 
CG4144 -1,538 Gram-negative bacteria binding protein 2 
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CG9907 -1,538 paralytic 
CG13616 -1,536 CG13616 
CG13390 -1,531 CG13390 
CG5006 -1,531 Odorant receptor 33c 
CG5370 -1,527 Death caspase-1 
CG30322 -1,526 - 
CG7023 -1,525 CG7023 
CG32172 -1,522 noe 
CG10700 -1,520 CG10700 
CG12895 -1,519 CG12895 
CG3719 -1,518 CG3719 
CG6914 -1,513 CG6914 
CG15918 -1,510 CG15918 
CG17051 -1,507 dodo 
CG4226 -1,507 -- 
CG3382 -1,501 Organic anion transporting polypeptide 58Db 
CG13050 -1,500 - 
Table 7: List of upregulated genes upon ectopically activated metalloproteinase-1strain 
(Dm-mmp1)   
Gene ID Ratio of medians Name 
CG13380 8.064 CG13380 
CG8223 6.652 CG8223 
CG13155 5.781 CG13155 
CG31513 5.634 CG31513 
CG1361 4.838 Andropin 
CG9074 4.822 Male-specific RNA 57Da 
CG3018 4.674 - 
CG2665 4.653 Protein ejaculatory bulb II 
CG18064 4.568 Met75Cb 
CG18628 4.532 CG18628 
CG9108 4.414 Regulator of G-protein signalling 7 
CG10712 4.242 Chromator 
CG31061 4.236 Gustatory receptor 98d 
CG14645 4.209 CG14645 
CG11192 4.117 CG11192 
CR32911 4.105 - 
CG18778 4.08 CG18778 
CG5465 3.859 Mediator complex subunit 16 
CG9120 3.855 Lysozyme X 
CG31033 3.711 CG31033 
CG13933 3.66 CG13933 
CG11999 3.654 CG11999 
CG17673 3.554 Accessory gland peptide 70A 
CG9153 3.526 CG9153 
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CG1262 3.51 Accessory gland peptide 62F 
CG15464 3.485 CG15464 
CG16762 3.464 CG16762 
CG1691 3.404 IGF-II mRNA-binding protein 
CG15528 3.386 CG15528 
CG5683 3.372 Adult enhancer factor 1 
CR32899 3.354 - 
CG18646 3.353 CG18646 
CG8424 3.328 CG8424 
CG31762 3.287 arrest 
CG5556 3.262 CG5556 
CG13225 3.241 Odorant receptor 47a 
CG10910 3.237 CG10910 
CG31056 3.236 Accessory gland-specific peptide 98AB 
CG14560 3.199 male-specific opa containing gene 
CG14000 3.144 CG14000 
CG13324 3.131 CG13324 
CG8779 3.102 neuromusculin 
CG13097 3.087 CG13097 
CG15394 3.087 CG15394 
CG13375 3.055 CG13375 
CG15068 3.05 CG15068 
CG1265 3.043 CG1265 
CG7715 3.035 CG7715 
CG32950 3.002 - 
CR32893 2.97 - 
CG9920 2.965 CG9920 
CG8579 2.954 Jonah 44E 
CG9111 2.897 - 
CG15874 2.882 CG15874 
CG14676 2.875 CG14676 
CG9116 2.872 Lysozyme P 
CG32800 2.853 - 
CG31747 2.839 Gustatory receptor 36a 
CG9335 2.838 CG9335 
CG31369 2.834 CG31369 
CG32569 2.822 CG32569 
CG12524 2.814 CG12524 
CG31872 2.803 CG31872 
CG31412 2.801 CG31412 
CG10724 2.733 CG10724 
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CG3532 2.718 CG3532 
CG9166 2.716 312 
CG6283 2.715 CG6283 
CG13702 2.693 allatostatin C receptor 2 
CG7160 2.685 CG7160 
CG18030 2.68 Jonah 99Fi 
CG5097 2.655 Metallothionein C 
CG9029 2.65 CG9029 
CG6084 2.648 CG6084 
CG12902 2.611 CG12902 
CG30473 2.602 Odorant-binding protein 51a 
CG9976 2.601 Galactose-specific C-type lectin 
CG2010 2.595 CG2010 
CG13223 2.591 CG13223 
CG10154 2.585 CG10154 
CG13003 2.582 CG13003 
CG5008 2.58 Gram-negative bacteria binding protein 3 
CG4181 2.575 Glutathione S transferase D2 
CG4894 2.563 - 
CG5399 2.557 CG5399 
CG8343 2.54 CG8343 
CG7144 2.538 CG7144 
CG13510 2.536 CG13510 
CG17389 2.529 CG17389 
CG4649 2.515 Sorbitol dehydrogenase-2 
CG7470 2.511 CG7470 
CG32302 2.51 CG32302 
CG17012 2.498 CG17012 
CG4755 2.493 RhoGAP92B 
CG8569 2.487 CG8569 
CG9080 2.478 CG9080 
CG3411 2.471 blistered 
CG6919 2.468 octopamine receptor 2 
CG1079 2.467 CG1079 
CG7245 2.466 - 
CG3656 2.462 Cytochrome P450-4d1 
CG5815 2.452 CG5815 
CG17063 2.446 inx6 
CG10852 2.422 Accessory gland peptide 63F 
CG8228 2.414 CG8228 
CG13315 2.412 CG13315 
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CG2611 2.412 CG2611 
CG17956 2.409 Male-specific RNA 87F 
CG4485 2.405 Cytochrome P450-9b1 
CG13293 2.401 CG13293 
CG6403 2.399 CG6403 
CG4187 2.398 CG4187 
CG14322 2.396 CG14322 
CG10262 2.394 CG10262 
CG18279 2.393 Immune induced molecule 10 
CG6372 2.385 CG6372 
CG17309 2.376 C-terminal Src kinase 
CG3850 2.374 sugarbabe 
CG31537 2.373 CG31537 
CG17876 2.362 Amylase distal 
CG8952 2.359 CG8952 
CG16996 2.352 CG16996 
CG10562 2.35 CG10562 
CG14302 2.349 CG14302 
CG15616 2.348 Acp53C14b 
CG8749 2.348 small nuclear ribonucleoprotein 70K 
CG18107 2.34 CG18107 
CG10279 2.329 Rm62 
CG8134 2.327 CG8134 
CG3408 2.326 CG3408 
CR33356 2.323 - 
CG7697 2.321 Cleavage stimulation factor 64 kilodalton subunit 
CG3219 2.32 Klp59C 
CG14670 2.317 CG14670 
CG2577 2.314 CG2577 
CG11961 2.31 CG11961 
CG32707 2.305 Anaphase Promoting Complex 4 
CG30029 2.3 CG30029 
CG7742 2.297 CG7742 
CG12225 2.296 Spt6 
CG11820 2.284 CG11820 
CG5016 2.284 Male-specific RNA 57Db 
CG8784 2.284 CG8784 
CG17945 2.283 Male-specific RNA 84Dc 
CG13614 2.282 CG13614 
CG7518 2.273 CG7518 
CG7197 2.254 CG7197 
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CG10505 2.245 CG10505 
CG6503 2.234 CG6503 
CG18106 2.229 Immune induced molecule 2 
CG7896 2.222 CG7896 
CG3184 2.22 CG3184 
CG18594 2.219 CG18594 
CG5004 2.214 CG5004 
CG1775 2.209 Medea 
CG10824 2.205 CG10824 
CG7757 2.2 CG7757 
CG7714 2.188 CG7714 
CG11864 2.183 CG11864 
CG12879 2.178 CG12879 
CR32905 2.177 - 
CG14346 2.175 CG14346 
CG7874 2.167 CG7874 
CG32118 2.164 CG32118 
CG17191 2.161 CG17191 
CR32901 2.16 - 
CG8871 2.155 Jonah 25Biii 
CG16978 2.15 CG16978 
CG10348 2.149 CG10348 
CG14330 2.148 CG14330 
CG14795 2.129 CG14795 
CG11295 2.128 lethal-(2)-denticleless 
CG14916 2.124 Gustatory receptor 32a 
CG4795 2.123 Calphotin 
CG10347 2.113 CG10347 
CG10587 2.11 CG10587 
CG13561 2.091 CG13561 
CG9496 2.084 Tetraspanin 29Fb 
CG13722 2.083 CG13722 
CG18130 2.082 CG18130 
CG6355 2.074 CG6355 
CG15829 2.073 CG15829 
CG1462 2.068 Alkaline phosphatase 4 
CG2559 2.061 - 
CG3497 2.055 Suppressor of Hairless 
CG4213 2.054 CG4213 
CG3492 2.047 CG3492 
CG8195 2.043 CG8195 
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CG13323 2.035 CG13323 
CG4630 2.032 CG4630 
CG10184 2.029 CG10184 
CG13630 2.027 CG13630 
CG13937 2.027 CG13937 
CG4183 2.024 Heat shock protein 26 
CG33115 2.022 CG33115 
CG7546 2.02 CG7546 
CG16749 2.018 CG16749 
CG5279 2.016 Rhodopsin 5 
CG7398 2.01 Transportin 
CG18444 2.009 - 
CG2047 2.008 fushi tarazu 
CG13460 2.005 CG13460 
CG32952 2.003 - 
CG2171 1.991 Triose phosphate isomerase 
CG3924 1.991 Chip 
CG4463 1.985 Heat shock protein 23 
CG9485 1.978 CG9485 
CG1776 1.966 CG1776 
CG10934 1.964 CG10934 
CG7918 1.96 CG7918 
CG12794 1.951 la costa 
CG12865 1.948 CG12865 
CG7702 1.945 CG7702 
CR32910 1.942 - 
CG11124 1.938 secretory Phospholipase A2 
CG14965 1.937 CG14965 
CG12452 1.936 CG12452 
CR32730 1.936 - 
CG13946 1.925 CG13946 
CG16740 1.925 Rhodopsin 2 
CG12787 1.922 hoepel1 
CG3194 1.922 - 
CG32192 1.92 CG32192 
CG17027 1.904 CG17027 
CG3298 1.899 Juvenile hormone-inducible protein 1 
CG16908 1.896 CG16908 
CG31145 1.896 CG31145 
CG9738 1.895 MAP kinase kinase 4 
CG4703 1.888 Arc42 
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CG33281 1.887 - 
CG11624 1.883 Ubiquitin-63E 
CG33041 1.883 CG33041 
CG6841 1.877 CG6841 
CG41123 1.863 - 
CG4351 1.862 CG4351 
CG8651 1.862 trithorax 
CG9938 1.853 CG9938 
CG1128 1.85 - 
CG3868 1.838 CG3868 
CG31893 1.837 Peritrophin-15b 
CG5778 1.833 CG5778 
CG1709 1.828 Vha100-1 
CG3843 1.827 Ribosomal protein L10Aa 
CG18103 1.825 fos-related gene at 28F 
CG7710 1.825 - 
CG5270 1.823 CG5270 
CG13983 1.821 CG13983 
CG18480 1.819 CG18480 
CG17108 1.818 CG17108 
CG3394 1.806 CG3394 
CG13737 1.803 CG13737 
CG2229 1.8 Jonah 99Fii 
CG3458 1.797 - 
CG30028 1.792 - 
CG11099 1.79 CG11099 
CG18648 1.788 - 
CG3206 1.785 Odorant receptor 2a 
CG5804 1.766 CG5804 
CG12891 1.76 mitochondrial carnitine palmitoyltransferase I 
CG8213 1.76 CG8213 
CG8293 1.756 Inhibitor of apoptosis 2 
CG41136 1.754 - 
CG7556 1.751 CG7556 
CG7803 1.75 zeste 
CG11529 1.747 CG11529 
CG5612 1.745 CG5612 
CG7851 1.745 - 
CG6966 1.738 CG6966 
CG7719 1.733 greatwall 
CG10265 1.732 CG10265 
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CG4879 1.731 homolog of RecQ 
CG5682 1.73 CG5682 
CG6467 1.729 Jonah 65Aiv 
CG33096 1.728 CG33096 
CG9271 1.728 Vitelline membrane 34Ca 
CG32633 1.727 CG32633 
CG7017 1.72 CG7017 
CG15347 1.719 CG15347 
CG9300 1.719 CG9300 
CG7564 1.718 CG7564 
CG14445 1.717 CG14445 
CG8194 1.708 Ribonuclease X25 
CG4221 1.7 CG4221 
CG11089 1.699 CG11089 
CG2260 1.699 CG2260 
CG14218 1.696 CG14218 
CG1112 1.693 - 
CG3331 1.692 ebony 
CG18160 1.688 - 
CG14088 1.682 CG14088 
CG10001 1.676 Allatostatin Receptor 2 
CG1107 1.668 - 
CG7758 1.666 pumpless 
CG9525 1.663 CG9525 
CG10297 1.654 Acp65Aa 
CG15231 1.654 Immune induced molecule 4 
CG13326 1.651 CG13326 
CG1837 1.647 CG1837 
CG7802 1.646 CG7802 
CG4533 1.644 lethal (2) essential for life 
CG7131 1.64 CG7131 
CG32796 1.639 CG32796 
CG17738 1.638 CG17738 
CG11314 1.635 CG11314 
CG14049 1.635 Ilp6 
CG8253 1.635 tungus 
CG9793 1.634 CG9793 
CG12501 1.632 Odorant receptor 56a 
CG14249 1.632 beat-VII 
CG12057 1.628 CG12057 
CG4525 1.626 CG4525 
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CG17083 1.622 CG17083 
CG31839 1.622 CG31839 
CG1324 1.619 CG1324 
CG8256 1.619 lethal (2) k05713 
CG17002 1.618 CG17002 
CG10225 1.615 CG10225 
CG2200 1.615 CG2200 
CG9615 1.615 tex 
CG10590 1.614 CG10590 
CG1939 1.614 CG1939 
CG14262 1.613 CG14262 
CG3328 1.612 CG3328 
CG5210 1.611 Chitinase-like 
CG5793 1.607 CG5793 
CG12952 1.606 salivary gland-expressed bHLH 
CG1304 1.606 CG1304 
CG6483 1.604 Jonah 65Aiii 
CG6687 1.6 CG6687 
CG17735 1.599 CG17735 
CG12820 1.593 CG12820 
CG3050 1.587 Cyp6d5 
CG31611 1.586 His4:CG31611 
CG10248 1.585 Cytochrome P450-6a8 
CG12491 1.575 CG12491 
CG4863 1.569 Ribosomal protein L3 
CG4260 1.567 - 
CR30024 1.566 - 
CG17999 1.56 CG17999 
CG10781 1.558 new glue 1 
CG30501 1.558 CG30501 
CG1453 1.557 Klp10A 
CG4859 1.557 Matrix metalloproteinase 1 
CG4617 1.552 CG4617 
CG9506 1.551 slow as molasses 
CG12350 1.548 - 
CR9700 1.548 - 
CG13617 1.545 CG13617 
CG15422 1.544 CG15422 
CG32717 1.542 stardust 
CG13176 1.537 CG13176 
CG4838 1.534 beaten path Ic 
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CG14217 1.533 Tao-1 
CR32894 1.529 - 
CG13693 1.528 CG13693 
CG31049 1.526 - 
CG4095 1.522 CG4095 
CG13719 1.521 CG13719 
CG13947 1.521 CG13947 
CG17245 1.521 plexin B 
CG18335 1.517 CG18335 
CG3883 1.516 CG3883 
CG14546 1.506 - 
CG33134 1.504 death executioner Bcl-2 homologue 
CG13422 1.502 CG13422 
Table 8: List of down regulated genes upon ectopically activated metalloproteinase-
1strain (Dm-mmp1)   
Gene ID Ratio of medians Name 
CG10250 -8.198 nautilus 
CG31852 -6.844 Two A-associated protein of 42kDa 
CG32091 -4.686 CG32091 
CG40214 -4.618 - 
CG33472 -4.565 - 
CG3815 -4.403 CG3815 
CG31619 -4.18 CG31619 
CG15499 -4.123 CG15499 
CG12042 -4.043 CG12042 
CG13601 -3.899 CG13601 
CG15355 -3.826 - 
CG3125 -3.77 lethal (1) G0060 
CG1801 -3.753 - 
CG15380 -3.731 - 
CG5913 -3.689 CG5913 
CG4552 -3.586 CG4552 
CG31178 -3.562 CG31178 
CG6210 -3.561 Multidrug-Resistance like Protein 1 
CG3983 -3.494 CG3983 
CG14259 -3.486 CG14259 
CG9632 -3.456 CG9632 
CG17683 -3.437 - 
CG5225 -3.328 CG5225 
CG31247 -3.328 tincar 
CG10391 -3.287 Cyp310a1 
Appendix 
 130
CG4020 -3.285 CG4020 
CG5038 -3.259 CG5038 
CG32986 -3.22 CG32986 
CG2854 -3.198 - 
CG13281 -3.172 CAS/CSE1 segregation protein 
CG5830 -3.168 CG5830 
CG14523 -3.16 CG14523 
CG7400 -3.11 Fatty acid (long chain) transport protein 
CG8233 -3.088 CG8233 
CG15556 -3.062 CG15556 
CG10017 -3.055 CG10017 
CG9606 -3.025 Rrp45 
CG12272 -3.008 CG12272 
CG2254 -2.992 CG2254 
CG30036 -2.974 CG30036 
CG12653 -2.935 buttonhead 
CG17290 -2.926 CG17290 
CG1539 -2.926 tropomodulin 
CG1279 -2.897 Rtnl2 
CG9149 -2.89 CG9149 
CG2160 -2.874 Suppressor of Cytokine Signaling at 44A 
CG10563 -2.849 CG10563 
CG13625 -2.819 CG13625 
CG3006 -2.813 Flavin-containing monooxygenase 1 
CG9820 -2.769 Odorant receptor 59a 
CG32473 -2.754 CG32473 
CG7421 -2.748 Nopp140 
CG10207 -2.738 Na 
CG31016 -2.732 - 
CG5646 -2.723 CG5646 
CG15418 -2.707 CG15418 
CG5787 -2.696 CG5787 
CG11873 -2.666 CG11873 
CG6671 -2.649 Argonaute 1 
CG7615 -2.646 fos intronic gene 
CG5543 -2.636 CG5543 
CG11210 -2.632 CG11210 
CG1912 -2.63 - 
CG30088 -2.621 CG30088 
CG9362 -2.62 CG9362 
CG5073 -2.575 CG5073 
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CG12161 -2.572 CG12161 
CG32512 -2.566 CG32512 
CG2062 -2.552 Cytochrome P450-4e1 
CG10039 -2.551 CG10039 
CG1499 -2.533 CG1499 
CG7762 -2.524 Rpn1 
CG4302 -2.522 CG4302 
CG31519 -2.515 Odorant receptor 82a 
CG1495 -2.511 Calcium/calmodulin-dependent protein kinase I 
CG3739 -2.503 CG3739 
CG13127 -2.499 CG13127 
CG6870 -2.497 CG6870 
CG9597 -2.486 CG9597 
CG6394 -2.486 UDP-N-acetyl- 
CG40449 -2.478 - 
CG7058 -2.469 CG7058 
CR32900 -2.462 - 
CG1732 -2.453 CG1732 
CG6476 -2.452 Suppressor of variegation 3-9 
CG7290 -2.448 CG7290 
CG10988 -2.446 lethal (1) discs degenerate 4 
CG9209 -2.443 vacuolar peduncle 
CG7535 -2.432 - 
CG17764 -2.43 CG17764 
CG14620 -2.42 touch insensitive larva B 
CG17049 -2.417 CG17049 
CG15233 -2.394 CG15233 
CG13898 -2.394 CG13898 
CG5237 -2.384 CG5237 
CG5867 -2.378 CG5867 
CG12158 -2.377 - 
CG16801 -2.371 CG16801 
CG15641 -2.371 CG15641 
CG14017 -2.359 CG14017 
CG13011 -2.358 CG13011 
CG30017 -2.349 CG30017 
CG1513 -2.339 CG1513 
CG13270 -2.331 Ugt36Ba 
CG6074 -2.327 CG6074 
CG10660 -2.327 CG10660 
CG31626 -2.32 CG31626 
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CG6120 -2.316 Tetraspanin 96F 
CG9899 -2.308 CG9899 
CG14501 -2.3 - 
CG3191 -2.299 CG3191 
CG6061 -2.284 Myb-interacting protein 120 
CG11329 -2.282 CG11329 
CG1630 -2.274 Inositol 1 
CG15636 -2.272 CG15636 
CG8664 -2.215 CG8664 
CG16790 -2.206 CG16790 
CG31742 -2.203 CG31742 
CG32341 -2.2 CG32341 
CG1651 -2.189 Ankyrin 
CG10086 -2.189 CG10086 
CG9723 -2.182 - 
CG12818 -2.163 CG12818 
CG14459 -2.16 CG14459 
CG17760 -2.159 CG17760 
CG13178 -2.154 CG13178 
CG10174 -2.144 - 
CG31336 -2.142 Gustatory receptor 93b 
CG5494 -2.137 CG5494 
CG11156 -2.136 mutagen-sensitive 101 
CG31810 -2.132 CG31810 
CG2145 -2.126 CG2145 
CG10949 -2.119 CG10949 
CG7771 -2.117 single-minded 
CG32655 -2.116 CG32655 
CG1407 -2.114 CG1407 
CG3713 -2.102 CG3713 
CG3203 -2.101 Ribosomal protein L17 
CG32485 -2.098 CG32485 
CG1231 -2.098 CG1231 
CG13558 -2.097 CG13558 
CG8590 -2.09 Kinesin-like protein at 3A 
CG31090 -2.09 CG31090 
CG12663 -2.09 CG12663 
CG12278 -2.079 CG12278 
CG15861 -2.076 CG15861 
CG7080 -2.072 CG7080 
CG12023 -2.071 GV1 
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CG11129 -2.069 Yolk protein 3 
CG12530 -2.057 Cdc42 
CG16959 -2.054 CG16959 
CG12028 -2.051 disembodied 
CG8118 -2.05 mastermind 
CG13741 -2.049 CG13741 
CG13363 -2.048 Suv4-20 
CG12250 -2.043 CG12250 
CG14247 -2.035 CG14247 
CG7325 -2.031 Eig71Ek 
CG1743 -2.023 Glutamine synthetase 2 
CG13425 -2.023 bancal 
CG3572 -2.02 visceral mesodermal armadillo-repeats 
CG14211 -2.013 CG14211 
CG12408 -2.007 - 
CG11983 -2.004 CG11983 
CG7370 -2.003 CG7370 
CG13436 -2 CG13436 
CG3171 -1.997 trapped in endoderm-1 
CG11527 -1.997 Tiggrin 
CG8442 -1.996 Glutamate receptor I 
CG11422 -1.995 Olfactory-specific E 
CG4439 -1.988 CG4439 
CG7552 -1.982 - 
CG8925 -1.981 CG8925 
CG3790 -1.98 CG3790 
CG14122 -1.979 CG14122 
CG4558 -1.978 CG4558 
CG7992 -1.977 CG7992 
CG7861 -1.976 CG7861 
CG31304 -1.974 CG31304 
CG14495 -1.97 CG14495 
CG17759 -1.969 - 
CG10399 -1.969 CG10399 
CG7881 -1.965 CG7881 
CG3376 -1.96 CG3376 
CG5352 -1.957 Small ribonucleoprotein particle protein B 
CG12781 -1.956 nahoda 
CG8782 -1.954 Ornithine aminotransferase precursor 
CG5893 -1.952 Dichaete 
CG5232 -1.95 Sialic acid phosphate synthase 
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CG18510 -1.942 - 
CG5216 -1.94 Sir2 
CG5079 -1.935 CG5079 
CG4373 -1.933 Cyp6d2 
CG3725 -1.933 Calcium ATPase at 60A 
CG10695 -1.933 Pat1 
CG32134 -1.929 breathless 
CG1983 -1.919 CG1983 
CG13951 -1.919 lethal (2) k10201 
CG8234 -1.912 CG8234 
CG3732 -1.912 CG3732 
CG13392 -1.911 CG13392 
CG40346 -1.907 - 
CG9806 -1.898 CG9806 
CG32239 -1.897 Guanine nucleotide exchange factor GEF64C 
CG9471 -1.892 CG9471 
CG5790 -1.89 CG5790 
CG15028 -1.89 CG15028 
CG15522 -1.889 CG15522 
CG3757 -1.887 yellow 
CG6192 -1.885 CG6192 
CG31385 -1.884 - 
CG15144 -1.884 CG15144 
CG10701 -1.884 Moesin 
CG33005 -1.881 - 
CG32549 -1.877 CG32549 
CG7384 -1.875 CG7384 
CG14959 -1.875 CG14959 
CG7149 -1.873 CG7149 
CG11801 -1.873 CG11801 
CG4676 -1.871 CG4676 
CG32685 -1.87 CG32685 
CG18783 -1.867 Kruppel homolog 1 
CG5708 -1.866 CG5708 
CG3835 -1.861 CG3835 
CG7164 -1.857 CG7164 
CG14972 -1.855 CG14972 
CG8687 -1.854 Cyp6a14 
CG7904 -1.85 punt 
CG6761 -1.843 CG6761 
CG6435 -1.843 CG6435 
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CG17118 -1.843 CG17118 
CG1629 -1.839 yellow-h 
CG14536 -1.839 CG14536 
CG5036 -1.83 CG5036 
CG5303 -1.829 meiotic from via Salaria 332 
CG3612 -1.828 bellwether 
CG14511 -1.828 CG14511 
CG5025 -1.826 Selenophosphate synthetase 2 
CG11412 -1.824 CG11412 
CG10699 -1.824 Lim3 
CG33341 -1.823 - 
CG1411 -1.823 - 
CG10778 -1.82 CG10778 
CG30338 -1.819 CG30338 
CG1072 -1.815 Arrowhead 
CG3655 -1.808 CG3655 
CG33302 -1.806 CG33302 
CG32984 -1.806 CG32984 
CG1394 -1.806 CG1394 
CG4151 -1.805 - 
CG10244 -1.805 Cad96Ca 
CG10582 -1.804 Sex-lethal interactor 
CG41042 -1.801 - 
CG5889 -1.798 Mdh 
CG12118 -1.798 CG12118 
CG32599 -1.794 CG32599 
CG17386 -1.793 CG17386 
CG12035 -1.783 CG12035 
CG6730 -1.782 Cyp4d21 
CG3454 -1.782 Histidine decarboxylase 
CG15166 -1.78 CG15166 
CG15345 -1.779 CG15345 
CG6967 -1.773 CG6967 
CG2096 -1.771 flap wing 
CG6717 -1.767 - 
CG16963 -1.766 Crystallin 
CG4563 -1.762 CG4563 
CG15101 -1.762 Juvenile hormone epoxide hydrolase 1 
CG6657 -1.761 vegetable 
CG9875 -1.759 CG9875 
CG3705 -1.759 astray 
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CG32365 -1.758 CG32365 
CG9568 -1.757 CG9568 
CG32428 -1.75 CG32428 
CG14517 -1.746 - 
CG17347 -1.741 CG17347 
CG8311 -1.738 CG8311 
CG5451 -1.732 CG5451 
CG30396 -1.732 Gustatory receptor 58a 
CG13563 -1.731 CG13563 
CG32195 -1.729 CG32195 
CG12677 -1.728 CG12677 
CG3077 -1.727 CG3077 
CG6562 -1.725 synaptojanin 
CG30450 -1.721 Odorant-binding protein 56f 
CG33455 -1.72 CG33455 
CG15884 -1.72 CG15884 
CG15710 -1.719 CG15710 
CG11471 -1.717 Isoleucyl-tRNA synthetase 
CG32088 -1.716 CG32088 
CG15196 -1.715 CG15196 
CG12617 -1.713 CG12617 
CG8730 -1.712 drosha 
CG4962 -1.71 CG4962 
CG2004 -1.706 CG2004 
CG9900 -1.703 - 
CG2835 -1.702 - 
CR32665 -1.701 - 
CG9428 -1.701 Zinc/iron regulated transporter-related protein 1 
CG11592 -1.698 CG11592 
CG9815 -1.691 CG9815 
CG7361 -1.69 - 
CG16732 -1.69 CG16732 
CG12835 -1.682 CG12835 
CG5222 -1.681 CG5222 
CG8580 -1.676 - 
CG30419 -1.674 CG30419 
CG18809 -1.674 CG18809 
CG5644 -1.671 CG5644 
CG17952 -1.671 - 
CG8007 -1.667 CG8007 
CG5998 -1.665 Adenosine deaminase-related growth factor B 
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CG5241 -1.664 CG5241 
CG31084 -1.664 CG31084 
CG14593 -1.66 CG14593 
CG3502 -1.655 CG3502 
CG7573 -1.651 - 
CG32629 -1.648 CG32629 
CG2706 -1.648 female sterile (1) Yb 
CG3740 -1.645 CG3740 
CG8885 -1.643 CG8885 
CG1169 -1.643 Osiris 18 
CG7820 -1.642 Carbonic anhydrase 1 
CG15293 -1.64 CG15293 
CG31694 -1.639 CG31694 
CG13126 -1.638 CG13126 
CG14551 -1.636 CG14551 
CG6106 -1.635 CG6106 
CG13538 -1.632 CG13538 
CG11373 -1.631 CG11373 
CG32486 -1.627 CG32486 
CG10470 -1.627 CG10470 
CG41107 -1.624 - 
CG13541 -1.622 CG13541 
CG16918 -1.62 CG16918 
CG13643 -1.62 CG13643 
CG8051 -1.609 CG8051 
CG33493 -1.608 - 
CG14512 -1.607 - 
CG10005 -1.605 CG10005 
CG10243 -1.601 Cyp6a19 
CG6094 -1.599 CG6094 
CG11847 -1.596 CG11847 
CG10698 -1.593 GRHRII 
CG30337 -1.591 CG30337 
CG18467 -1.59 CG18467 
CG11110 -1.589 CG11110 
CG33136 -1.587 CG33136 
CG40198 -1.586 - 
CG9594 -1.584 Chd3 
CG1066 -1.583 Shaker cognate b 
CG6056 -1.58 - 
CG31795 -1.574 ia2 
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CG4005 -1.572 CG4005 
CG18669 -1.572 CG18669 
CG12224 -1.568 CG12224 
CG12576 -1.566 CG12576 
CG31778 -1.564 CG31778 
CR40474 -1.561 - 
CG3599 -1.56 CG3599 
CG12348 -1.557 Shaker 
CG14756 -1.551 CG14756 
CG14491 -1.551 CG14491 
CG11922 -1.551 forkhead domain 96Cb 
CG17838 -1.548 CG17838 
CG32167 -1.545 CG32167 
CG17023 -1.543 - 
CG13318 -1.541 CG13318 
CG11788 -1.541 CG11788 
CG14958 -1.533 CG14958 
CG7103 -1.531 PDGF- and VEGF-related factor 1 
CG15916 -1.531 CG15916 
CG10535 -1.529 CG10535 
CG14089 -1.527 CG14089 
CG7140 -1.526 CG7140 
CG14618 -1.524 CG14618 
CG10211 -1.522 CG10211 
CR31940 -1.52 - 
CG14396 -1.518 Ret oncogene 
CG13111 -1.513 CG13111 
CG7408 -1.51 CG7408 
CG12560 -1.509 CG12560 
CG1218 -1.509 CG1218 
CG10164 -1.508 CG10164 
CG15296 -1.506 CG15296 
CG18773 -1.502 Lcp65Ab2 
CG10117 -1.502 tout-velu 
CG17390 -1.5 CG17390 
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Figure 38: Fly construction scheme 
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